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Thesis directed by Professor Donough O'Brien
The unsatisfactory state of current methods for the measurement 
of iron in serum or plasma is revealed by a review of recent 
literature. This was confirmed by a critical examination of three 
representative and widely used colorimetric iron procedures. The 
deficiencies of these methods, namely poor reproducibility and 
inadequate recovery of iron added to serum, were found to be 
compounded to a degree of unacceptability by the very marked inhibit 
ion of color production caused by the presence in serum of the power 
ful iron chelator desferrioxamine. Attempts to improve the best of 
these colorimetric procedures were only partially successful.
Atomic absorption spectrophotometry was investigated as a 
means of quantitating serum iron, with the view of developing a 
procedure which not only fulfilled the usual requirements of 
reproducibility, and specificity, but in addition was unaffected 
by the presence in serum of a physiological concentration of 
desferrioxamine, a compound commonly used for the treatment of 
iron poisoning.
Conventional methodology for this type of analysis was found 
to be unsatisfactory, due to the high degree of sensitivity required 
eliminating the possibility of sample dilution. Recorder curve
integration was examined and adopted as the means of quantitation. 
Marked inhibition of absorption due to phosphate was found. This 
was eliminated by the incorporation into standards of iron free 
protein, which while itself inhibiting absorption caused no 
cumulative effect with other anions. The method developed gave 
95% confidence limits of 6.88% with a mean recovery of added iron 
of 91.89%.
Using this means of quantitation, methods were devised for the 
measurement of the distribution of iron in serum in the presence of 
desferrioxamine. These revealed that iron is bound by this chelator 
as a logarithmic function of chelator concentration.
In vivo studies demonstrated that desferrioxamine is rapidly 
metabolized, while the iron complex of this chelator is not 
metabolized, but is rapidly cleared from the circulation by the
kidneys.
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INTRODUCTION
The presence of iron in plasma was anticipated long before 
Fontes and Thioville, in 1925, conclusively demonstrated both its 
existence and importance.(l) During the next five years this 
observation was confirmed and extended by Barkan, Henriques and 
Roche, and Warburg and Krebs.(2)(3)(*0(5) Barkan and Warburg also 
made the observation that the iron present in plasma could be 
neither dialyzed nor ultrafiltered and concluded that this was due 
to protein binding. It was now however until 19^9 that Surgenor 
and his co-workers working on the observations of Holmberg and 
Laurell, and Schade and Caroline, isolated a protein which migrated 
electrophoretically as a ^ -globulin and which bound specifically 
two atoms of ferric iron per molecule of protein.(6)(7)(8)(9)
This protein which was found to have a molecular weight of 90,000 
was named siderophilim or transferrin.(8)(10) Confirmation that 
transferrin is the transport mechanism for iron in the circulation 
came from radio-isotopic studies both in vivo and in vitro.(ll)(l2)
(13)
Iron Methodology
The confirmation of non-hemoglobin derived iron in plasma led
to the development and publication of numerous methods for its
estimation. In general, these methods follow the hroad principles
of releasing iron from transferrin, the removal of proteins by
2precipitation so that an optically clear solution may he obtained, 
and the complexing of the iron to a chromogen. Early methods 
accomplished the first step by wet acid digestion, hut fell into 
disrepute when it was shown that hemoglobin iron was also being 
estimated.(lU)(l5)(l6) Trichloroacetic acid has been proposed as 
an extractant but provides inadequate dissociation between iron and 
transferrin unless supplemented by heat .(17) (18) Indeed it has been 
suggested that a final acidic concentration equivalent to one normal 
hydrochloric acid is necessary for the complete disruption of the 
iron-transferrin bond in the cold.(19) The use of trichloroacetic 
acid as a protein precipitant only, subsequent to the use of another 
extractant, has also been criticized on the grounds of iron loss 
due to entrainment and coprecipitation and the frequency with which 
a turbid supernatant fluid is obtained •( 20)(21)(22)(23) The use 
of an acetate buffer and heat has been claimed to avoid the problem 
of coprecipitation, but unfortunately this technique also increases 
the frequency of turbidity interference •( 22)( 23)(24) (25) Methods 
based on the extraction of the chromogen-iron complex into iso-amyl 
alcohol thereby eliminating protein precipitation have been 
published.(17)(26)(27) These methods however, suffer from the dis­
advantages of also extracting bilirubin which causes a large positive 
error unless a blank correction is made, and in common with other 
extraction procedures are open to negative error due to incomplete 
extraction.(23)(28)(29)(30)(3l) The protein precipitation step 
has also been eliminated by the use of a detergent to solubulize 
both protein and iron-chromogen complex, and by the use of buffer 
to release iron from transferrin tinder rigidly controlled conditions
3such that the proteins are maintained in solution.(32)(33)(3*0 (35)(5*0 
It was observed early in the studies on the methodology of 
plasma iron quantitation that the addition of a reducing agent to 
the acidified plasma increased the rate of dissociation of the 
iron-transferrin complex.(36) Many workers have therefore incorporated 
reducing agents into methods both for this reason and since several 
of the chromogens described later, will only complex iron in the 
reduced (ferrous) state. Among the reducing agents used have been 
mercaptoacetic acid; sodium sulfite; sodium hydrosulfite; ascorbic 
acid; hydrazine; hydroxylamine; and hydroxylammonium chloride.(8)(17) 
(l9)(22)(23)(2l0(27)(3O)(32)(33)(37)(38)(39)(to)(te)(^3)W 
Chromogens
One of the earliest chromogens to be used in the measurement 
of iron in biological material was thiocyanate.(2)(l5)(26)(U-5)(l«-6)
This reagent however has many disadvantages in that the red 
ferrithiocyanate complex is unstable, it is extremely pH sensitive, 
interference from phosphate occurs, and sensitivity is low.(l8) 
Thiocyanate has been completely replaced by more specific compounds, 
the iron complexes of which have higher molar extinction coefficients. 
The first of these to be available, 1,10-phenanthroline found 
extensive use in iron methodology together with its derivative 
4,7-diphenyl 1,10-phenanthroline. (17) (19) (20) (27) (29) ( 30) ( 32) (^ 1)
(42)(^3) Perhaps the one disadvantage of these reagents was thexr 
insolubility in aqueous solutions. This drawback has been overcome 
by the preparation of the sulfonated derivatives which are water 
soluble.(2 3)(25)(3 7) 2,21-dipyridyl has been used, but has the 
disadvantage of being rather insensitive.(2 0)(2l)(22)(2^)(36)(39)(1+0 )
k2,2 ,2 -tripyridyl foras a much more highly colored complex with 
iron and although it has not as yet been widely used, would appear 
to be the reagent of choice.(33)(h k )(^7) Other reagents which have 
had a limited use are o-tolidine and 8-hydroxyquinoline. ( 31) (it8)
It is apparent from the diversity of methods and reagents 
used for the estimation of serum iron that this measurement has 
not totally fulfilled analytical requirements. This is confirmed by 
a comparison of the ranges of noimal values obtained by the methods 
published since 19^5, as shown in Table I.
Measurement of Iron-binding Capacity
As has been previously stated serum iron is carried as a complex 
with a ^-globulin called transferrin. Transferrin is however, only 
one quarter to one half saturated in noimal individuals, leaving 
a large fraction of the protein with a latent ability to bind more 
iron. The measurement of transferrin levels, while it may be achiev­
ed directly by the use of a specific precipitating antibody and 
immuno—electrophoresis, is more usually accomplished indirectly 
in terns of the ability of the protein to bind iron.(56)(57)(58)
This parameter is known as the total iron-binding capacity (T.I.B.C.) 
or if only that fraction of the transferrin which is not complexed 
with iron is measured, as the unsaturated iron-binding capacity 
(U.I.B.C.).
The methods used for determining the iron-binding capacity of 
serum fall into three broad categories. Firstly those dependent 
on the fact that the iron-transferrin complex is colored and has a 
characteristic absorbance at hjO mM and is therefore amenable to 
direct spectrophotometry. (6 ) Secondly those methods in which the
5Table I
NORMAL VALUES FOR SERUM IRON OBTAINED FROM THE LITERATURE
Number in 
Sample Sex Mean
Standard
Deviation
Range 
(Mean * 2SD) Ref.
1. 17 M 171 37 97-245 22
2. 34 n.s.* 119 41 37-201 27
3. 35 M 143 43 57-229 45
4. 33 MSF 120 22.5 65-175 23
5. 12 F 160 20 120-200 19
6. 13 M 182 23.5 125-239 19
7. 16 F 166 40.5 85-247 28
8. 12 M 168 32 102-235 28
9. 14 F 82 n.s. 27-142 34
10. 12 M 109 n.s. 63-160 34
11. 20 F 104 30 74-134 41
12. 20 M 126 21.5 83-169 41
13. 20 M 116 58 58-173 35
14. 20 F 107 62 45-169 35
15. 29 M 120 45 75-165 44
16. n.s. n.s. 110 16 78-142 49
17. 15 M 127 15 87-157 50
18. 15 F 123 10 103-143 50
19. 10 M 150 n.s. 110-170 51
20. 5 F 120 n.s. 78-170 51
21. n.s. M n.s. n.s. 79-195 52
22. n.s. F n.s. n.s. 44-176 52
23. 50 M&F 143. n.s. 70-286. 53.
24. n.s. n.s. 98 n.s. 1+4-155 55
25. 14 M 114 n.s. 78-150 63
26. 7 F 105 n.s. 69-134 63
27. 40 M 125 25.3 74-176 69
28. 40 F 101 24.4 62-150 69
29. 47 n.s. n.s. n.s. 1+4-357 198
* not specified
6addition to serum of excess iron is followed by the measurement 
of the amount required to saturate the transferrin. The third, 
and relatively unimportant, type of procedure by Which iron-binding 
capacity may be measured, is an in vivo technique, whereby serum 
total iron is measured five minutes after an intravenous iron load.
Hie direct photometric measurement of the U.I.B.C. has been 
used by many workers, however it is insensitive, and subject to 
interference from turbidity, hemolysis, or icteric serum.(9)(l8)(50) 
(52)(59)(60)(6l)(62)(63)(6lt)(65)(66)
The second type of procedure is in fact the oldest by which 
iron binding capacity has been measured. Laurell devised an 
ingenious technique whereby the excess iron remaining after the 
saturation of transferrin is ccmplexed with 1,10-phenanthroline, the 
iron-transferrin complex is then broken by the addition of hydro­
chloric acid and trichloroacetic acid which simultaneously removes 
the iron-phenanthroline complex by entrainment in the protein 
precipitate.(8)(6T) The released iron is then measured, the result 
being the total iron-binding capacity. This method has been used by 
several investigators, but has been found to give variable results. 
(18)(210(M)(68) Other adaptions of this procedure have been 
proposed using a variety of chromogens and the maintenance of 
protein in solution by the use of buffers. Frequently a single 
tube is used as both blank and, following the addition of chrcmogen, 
test.(33)(55)(69)(70) Due to the variability of results and the 
inability to perform the test on serum of high turbidity, these 
methods have been largely replaced by procedures in which the excess 
iron is removed following transferrin saturation. In one such method
7iron is added in the form of ferric ammonium citrate and the excess 
removed "by treatment with an anion exchange resin.(27) A total 
iron quantitation is then performed on the saturated serum to 
determine T.I.B.C. In a second procedure ferric chloride is added 
and the excess removed by adsorption onto magnesium carbonate.(40)
While the addition of ferric ammonium citrate and the use of an ion 
exchange resin works well in principle, it is completely unsatisfactory 
when transferrin is already saturated and non-transferrin bound iron 
is present in the serum, as is the case in iron ingestion. For
this reason the magnesium carbonate method must be preferred. The
59ion-exchange method has however been adapted to use Fe labelled 
ferric ammonium citrate, thereby enabling it to be used under all 
circumstances. (71) Earlier methods which utilized radioactive 
iron in which either the supernatant, or the precipitate, were 
counted, have been severely criticized on the grounds that there 
is considerable absorption of radioactive iron to the precipitate 
thereby causing results to be between 12 and 25 per cent high.(37) 
(72)(73)
The assessment of methods for the determination of iron- 
binding capacity is extremely difficult, since there is no 
absolute reference. It must be emphasized however, that the 
ultimate accuracy of any method will be completely dependent on the 
accuracy with which the final iron concentration is determined.
In general there is good agreement on normal values with a mean of 
between 300 and 3^ 0 ug/lOO ml and a range of 250 to too ml‘
(8)(18)(23)(2^)(27)(33)(1»-9)(50)(51<-)(6^ )(67)(68)(71)(7^ )
8Acute Iron Intoxication
Poisoning due to the ingestion of iron compounds has undoubtedly 
been known for many centuries.(75) The first report of death due 
to this cause was made by Forbes in 1947.(76) Since that time, 
with the increased clinical use of iron, reports of iron intoxications 
have increased in number each year, so that it is now estimated 
that in some parts of the world, iron intoxication is second only 
to salicylate as the most common cause of poisoning in children.(77) 
(78) (79) (80) In addition to the frequency with which ingestion 
occurs, the mortality rate of nearly 50$ makes this a problem of 
considerable magnitude.(8l)(82)
Ferrous sulfate is the compound most frequently responsible 
for poisoning, although ingestion of many other iron compounds 
have been reported. Conflicting findings have been published on 
the relative toxicity of various iron compounds.(79)(83)(84)(85)(86) 
Beutler et al have suggested that iron preparations -which are 
easily absorbed and hence most effective therapeutically will also 
be the most toxic.(75) The amounts of iron ingested in fatal cases 
have ranged from 4 to 18 grams, while recovery has been recorded 
following the ingestion of 15 grams.(8l)(82)(87)(88)
The clinical features of this toxicity have been described in 
detail in several reviews and in most case reports.(75)(79)(80)(8l)
The symptoms are nausea and abdominal pain occurring about
thirty minutes after ingestion, with vomiting, bloody diarrhea, 
pallor or cyanosis, followed quickly by drowsiness, and peripheral 
vascular collapse. It has been suggested that this vascular 
collapse is due to the release of ferritin, the intracellular
9iron-binding protein, into the circulation.(79)(89X 90) These 
features may be followed by the development of metabolic acidosis 
or respiratory alkalosis and cama.(80)(9l) Death occurs in 
approximately one quarter of the cases within four hours of 
ingestion.(75) A bi-phasic pattern of symptoms is frequently 
observed in which apparent recovery lasting eight to sixteen hours 
is followed by a recurrence of coma, collapse, and convulsions 
with pyrexia. Later manifestations are rare but have included 
pyloric stenosis and gastric fibrosis to a degree requiring 
surgery (9l)(92)(93)(9^)(l09)
Laboratory findings are variable but in general there is a 
leucocytosis with counts as high as 55,000 per cubic millimeter.(75) 
Plasma bicarbonate is frequently in the 10 to 15 milliequivalents 
per liter range.(80)(89)(96)(97) itopaiiment of liver function 
has been reported on the basis of hyperbilirubinemia, bilirubinuria, 
and elevated serum glutamic oxalacetic and glutamic pyruvic trans­
aminase levels.(97) Serum iron levels are most often in the 3,000 
to 5,000 Mg/100 ml raage, but higher values, in one case 30,000 pg/ 
100 ml, have been reported.(80)(89)(97)(98)(99) Aminoaciduria 
has been observed in one case.(91) Coagulation defects due to 
hypoprothrombinemia, thrombocytopenia, and decreased fibrinogen 
levels are known to occur.(100)(108)
Pathological studies show marked changes in the gastro­
intestinal tract, with necrosis, epithelial stripping, and diffuse 
congestion of the mucosa of the stomach.(96)(98X 101X 102) The lower 
tract may have iron deposits in the mucous membrane surface, in 
platelet thrombii, and in the small vesselB of the gut vall.(8l)(10l)
10
The liver frequently exhibits vascular congestion and small 
hemorrhagic areas. Iron depositions are seen microscopically in 
the Ktlpfer cells, portal vein endothelium, and periportal 
reticulum.(101) Other organs including the heart show edema and 
patches of hemmorhage.(75) Depositions of iron have also been 
recorded in the lumen of the renal tubules.(8 9)
The pathogenesis of iron poisoning is obscure. Many 
investigators have regarded the gastrointestinal lesions as 
fundamental, either as a direct corrosive effect or as a facilitation 
of access of iron to the blood stream.(8 9)(l03)(l0l4-) The latter 
would seem unlikely since several fatal cases of iron poisoning 
have been reported with no evidence of gastrointestinal lesions.
(102) (105) As has been previously stated the vaso-depressive 
properties of ferritin have been implicated as the cause of shock. 
(79)(8 9)(90) This however, due to the difficulty in measuring 
ferritin, lacks confirmation, although it has been observed that 
most of the iron in the circulation following the ingestion of 
large amounts of iron is non-dialyzable.(105)(106) It is also 
possible that the shock may be due to iron acting directly on 
blood vessels and eliciting a release of active compounds such as 
serotonin, histamine, or bradykinin.(l07) Tbis possibility has 
not been evaluated. It would appear that the consensus of 
informed opinion is in favor of shock, however caused, as the
pathogenic lesion of iron intoxication.
Until relatively recently most cases of acute iron intoxication
were treated solely with supportive measures to overcane shock, 
the induction of vomiting to remove unabsorbed iron, and gastric
11
lavage with sodium "bicarbonate solution to convert the ferrous salt 
to insoluble ferrous carbonate, in an attempt to prevent further 
absorption. Exchange transfusions have been reported to be 
beneficial, and peritoneal dialysis has been advocated, but would 
not appear to be useful since, as stated above, the non-transferrin 
bound iron is not dialyzable.(95)(98)(llO)(l05)
The concept of the removal of iron from the body by means of 
chelation has attracted many workers. Dimercaprol (British anti­
lewisite, B.A.L.) has been used for the treatment of two cases of 
acute iron ingest ion. (ill) (112) The results obtained were however 
contradictory and indeed, it would appear from subsequent work 
that B.A.L. increases the toxicity of ferrous sulfate by facilitating 
absorption without a significant increase in the rate of excretion.
(107) (113 ) (114) Foreman et al demonstrated that the use of a 
parenterally administered chelating agent was feasible and many such 
agents have since been used.(115) Calcium disodium ethylenediamine- 
tetraacetate (Edathamil, E.D.T.A.) has been used extensively and 
degrees of success have been claimed.( 8 0 ) ( 9 5 ) ( 9 T ) ( 9 8 ) ( H 7 ) ( H 8 )
It has been stated however that E.D.T.A. does not reduce the 
mortality in acute experimental iron poisoning. (107)( 119) This 
may be explained by the instability of the E.D.T.A.-iron complex 
at physiological pH. Other agents which have been used are
trisodium calcium diethylenetriaminepentaacetate and ethylene 
di (o-hydroxyphenylacetic acid).(l20)(l2l) The same criticism 
as that leveled against E.D.T.A. can be applied to these compounds, 
which Have at best, a limited therapeutic using in poisoning due to
iron compounds.
12
Recently a compound of great premise in the chelation therapy 
of acute iron intoxication has "become available. Desferrioxamine B 
was originally prepared from an iron containing complex isolated 
from Stre-ptomyces -pilosus. (122)(123) It is a compound made up of 
one molecvile of acetic acid, two molecules of succinic acid, and 
three molecules of 1 -amino-5 -hydroxylaminopentane, arranged to form 
a chain with three hydroxamic acid side groups and a terminal amino 
geo up • (12^) The structure of desferrioxamine and its iron complex 
(ferrioxamine) is shown in Figure 1. The complex is formed only 
with ferric ions and is of great stability having a formation or 
stability constant of 103°’6.(l25) The stability constants of 
other iron chelates are: E.D.T.A. 1025, D.T.P.A. 1029 and transferrin 
102?-T ^  10^°*2.(125) Thus desferrioxamine will readily and 
completely remove iron from ferritin and hemosiderin, but will 
have no effect on hemoglobin iron.(l2^) The degree to which iron is 
removed from transferrin by this chelator is the subject of conflicting 
reports. Keberle has stated that some 10 - 15 per cent of the iron 
is removed from totally saturated transferrin, which Schubert 
using more recent data on the binding constants of iron and trans­
ferrin has concluded that less than 1 per cent is removed.(12*0(125)
(126)
Desferrioxamine has been examined for its ability to remove iron 
from the body in cases of pathological iron deposition, thalassemia 
major, experimental iron intoxication, and in acute iron poisoning 
in children.(l2T)(l28)(l29)(l30)(l3D(l32)(l33)(l3 )^ 3* general,
published reports have been enthusiastic concerning the benefits 
produced by this therapy. In all cases however, the basis of this
: • . ’ ) . o : ■: • ~ V. *. sv: ;iv •/.' { )
\ ' ■
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9Figure 1. (a) Structure of desferrioxamine. (b) Structure of 
iron chelate of desferrioxamine (Ferrioxamine).
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endorsement of desferrioxamine therapy has been made primarily on 
the reduction seen in the serum iron levels following its initiation. 
Imhof has pointed out that free chelator present in serum will 
take up iron released from transferrin, and the resultant chelate 
may be entrained in the protein and carried down during protein 
precipitation. In addition, since the estimation of iron by the 
methods described earlier is dependent on what are essentially 
chelation reactions between a chramogenic ligand and the metal; it 
would be expected that the presence of a second, more powerful, 
chelator would set up a competitive situation such that the amount 
of iron combining with the chromogen would be reduced, with a 
consequent artificial lowering of the values obtained.
It was believed therefore that investigation of the standard 
chromogenic iron methods was necessary with respect to the validity 
of results obtained in the presence of desferrioxamine. Should 
the above factor prove to be effectively invalidating serum iron 
values, there then existed a requirement for a procedure which 
would permit not only the accurate assessment of the iron level 
of serum in the presence of the chelator, but would allow the 
distribution of iron between the bound (i.e. to transferrin or 
chelator) and unbound to be easily determined. It was considered 
essential that such a procedure fulfill stringent requirements of 
accuracy, specificity, and reproducibility.
In order to test the criticisms of chromogenic serum iron 
methods, it was decided to appraise three established procedures 
utilizing different chromogens. The methods were those of Ramsay, 
Fischer and Price, and Goodwin.(38)(to)(¥v) Each method is set 
out in detail ‘below:
The 2)2 >-Dipyridyl Procedure of Ramsay.(^ 0)
Reagents
1. Sodium Sulfite 0.1M
2. 2,2 '-Dipyridyl 0.1# in 3# acetic acid
3. Chloroform
I4.. stock Iron Standard (100 pg/ml). Ten milligrams of pure 
clean iron wire were dissolved in 0.5 ml of 6n hydrochloric 
acid and 0.5 ml of 6n nitric acid and made up to 100 ml
with deionized water.
5. Working iron Standards (50-250 pg/lOO ml). 0.5 - 2.5 ml 
of stock iron standard were diluted to 100 ml with 0.01N
hydrochloric acid.
Procedure
1. 1 ml of serum was pipetted into a 5 ml glass stoppered 
tube containing 1 ml of sodium sulfite solution. 1 ml of 
standard or 1 ml of deionized water for blank were similarly
treated•
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2. To each tube 1 ml of dipyridyl reagent was added.
3. The mixture was heated in a boiling water (93°C) bath
for 5 minutes and then cooled in running tap water (l8°c).
4. 1 ml of chloroform was added to each tube, which was then 
stoppered and shaken vigorously.
5. The tubes were centrifuged at 3>000 r.p.m. for 5 minutes.
6. The supernatant fluid was transfered to a spectrophotometer 
cuvette and the absorption of each sample read in a spectro­
photometer at 520 mjJ. with optical path of 10 mm.
7- The absorption of the contents of the blank tube was
subtracted from each reading and a standard curve plotted. 
Results for each test was obtained by comparison with 
the standard curve.
The Tripyridyl-s-triazine (T.P.T.Z.) Procedure of Fischer and Price.(44)
Reagents
1. Hydrochloric Acid 2N
2. Trichloroacetic Acid 20$ w/v
3. Tripyridyl-s-triazine O.OOltfl. 128.4 milligrams of T.P.T.Z. 
were dissolved in 1 ml of IN hydrochloric acid and diluted 
to 100 ml with deionized water.
4. Hydroxylammonium chloride 10$
5. Ammonium acetate 50$ w/v
6. Chromogen reagent. Immediately before use 2 volumes of 
ammonium acetate solution were mixed with 1 volume of 
hydroxylammonium chloride solution, and 1 volume of 
T.P.T.Z. solution.
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7• Stock and working iron standards were prepared as for 
previous method.
Procedure
1. 1.0 ml of serum was added to 0.5 ml of 2 NHC1. Agitated and 
then allowed to stand for 10 minutes. Blank (l ml deionized 
water) and standards were set up at the same time in a 
similar way.
2. 0 .5 ml of 20$ trichloroacetic acid was added to each tube and 
the contents mixed vigorously for 30 seconds.
3 . The tubes containing protein were centrifuged at 3,000 r.p.m. 
for 15 minutes.
k. 1.0 ml of clear supernatant fluid, or standard or blank 
solution was transfered to tubes containing 0.5 ml of 
chromogen reagent. The contents of each tube were mixed, 
and allowed to stand at room temperature for 10 minutes.
5. The contents of each tube were read against deionized water, 
in a spectrophotometer at 593 mpt.
6. After subtraction of the absorption of the reagent blank
from each reading the iron content was determined by comparison 
with the standard curve.
The Sulphonated Bathophenanthroline Method of Goodwin.(38)
Reagents
1. Hydrochloric Acid 2N
2. Ascorbic Acid 1$ w/v
3. Trichloroacetic Acid 20$ w/v
h. Ammonium Acetate U0$ w/v
5 . Sulphonated Bathophenanthroline 0.1$ w/v
18
6. Stock and working iron standards as for previous methods.
Procedure
1. 1 ml of serum was added to 1 ml of 2 HHC1 followed by 1 ml 
of 1$ ascorbic acid. The blank and standards were similarly 
treated. The contents of each tube were thoroughly mixed,
1 ml of 20$ trichloroacetic acid added, mixed again and 
allowed to stand for 10 minutes.
2. The protein containing tubes were centrifuged at 3,000 r.p.m. 
for 15 minutes.
3. 2 ml of clear supernatant fluid were transfered to a clean 
tube and 1 ml of 1+0$ ammonium acetate followed by 0.2 ml 
of sulphonated bathophenanthroline added to each tube. The 
contents were mixed and allowed to stand at room temperature 
for 5 minutes.
h. The absorption of the contents of each tube was read
against a deionized water reference cuvette, in a spectro­
photometer at 535 MM*
5. After subtraction of the reagent blank the iron concentration 
of each tube was obtained by comparison with the standard 
curve.
RESULTS OF INVESTIGATION OF COLORIMETRIC METHODS
A comparison of the standard curves for each of the above
methods showed that the sensitivity of the dipyridyl and the
bathophenanthroline methods was unsatisfactorily low. The absorbance
of a 100 [jg/lOO ml iron standard was 0.042 by the dipyridyl method,
and O.O78 by the bathophenanthroline method. By comparison the
figure obtained for the same iron standard by the T.P.T.Z. method,
0.182 was felt to be acceptable. The figure obtained for the
dipyridyl method was considered to be too low for- reliability.
This method is however the most widely used procedure for the
determination of serum iron in clinical laboratories and for this
reason the method was retained for comparative purposes in some of
the lata* studies.
In order to test the reproducibility of the bathophenanthroline
and the T.P.T.Z. method, pooled sera were analyzed by each method
ten times, together with ten aliquots of standard and blank. The
results obtained are shown in Table II (bathophenanthroline method)
and Table III (T.P.T.Z. method). These results, in particular
those obtained for the bathophenanthroline method, were felt to be
less than satisfactory. The experiment was repeated using the
bathophenanthroline method, however essentially the same result
(C.V. = 15.32$) was obtained. This poor reproducibilitytest
together with the insensitivity referred to previously warranted 
the elimination of the bathophenanthroline procedure from the study.
20
Table II
REPRODUCIBILITY OF BATHOPHENANTHROLINE METHOD
A. Serum Blank Test T-B(x) x-x
1. 069 111 042 4.4 Zx = 4642. 055 111 056 9.6 n = 103. 063 105 042 4.4 x = 46.44. 058 102 044 2.4 Z(x-x)2 = 310.405. 058 098 040 6.4
Z(x-x)2 .. _6. 047 098 051 4.6 n-1 = 34-48
7. 055 102 047 0.6
8. 058 097 039 7.4 /M*l|ii = 5.87 = S.D. v n-1
9. 053 106 053 6.6 S.D.-=—  X 100 = C.V.10.
B. 300 pg 
Standard
053 103 050 3.6 X.. C.V. = 12.65%
1. 055 231 176 5-.*» Zx = 1814
2. 044 223 179 2.4 n = 10
3. 039 226 187 5.6 R = 181.4
4. 043 228 185 3.6 Z(x-S)2 = 118.40
5. 042 226 184 2.6
i(r f 2 = i3.i5n-l6. 039 223 184 2.6
7. 039 216 177 4.4
I-^~y-- = 3.62 = S.D.8. 039 218 179 2.4 V n-1
9. 039 221 182 0.6 ^ 2 .^ x 100 = C.C.
X
10. 037 218 181 0.4 .. C.V. J = 1.99% stand.
95% confidence limits = -2 ’stand.* ^*^*test
= ±2 J3.96 + 160.02 
= ±25.6%
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Table III 
REPRODUCIBILITY OF T.P.T.Z. METHOD
A. Serum Blank Test T-B(x) x-mean(x)
1. 039 082 043 3.7 Ex = 4672. 038 090 052 5.3 n = 10
3. 038 085 047 0.3 3 = 46.7
4. 039 081 042 4.7 E(x-x)2 =160.1
5. 039 087 048 1.3 E(x-x)2n 1 = 17.796. OHO 087 047 0.3 n—x
7. 038 092 054 7.3 /l(X-St)2 _ H'22 = S.D.
8. 038 080 042 4.7 y n-1
9. 038 081 043 3.7 S:D* X 100 = C.V.
10. 038 087 049 2.3
A
C.V.test = 9*°3%
B.
Standard
1. 056 652 594 7.4 Ex = 6014
2. 038 639 601 0.4 n = 10
3. 037 639 602 0.6 S = 601.4
4. 036 641 605 3.6 E(x-x)2 = 292.4
5. 028 634 606 4.6 Zix--?.>2 = 32.49
6. 031 643 612 10.6 n-1
7. OH** 644 600 1.4 /e(x-x)2 _ 5 ?0 _ s D
8. 035 630 595 6.4 V n-1
9. 041 636 595 6.4 S,D* X 100 = C.V.X
10. 041 645 604 2.6 c-v-stm d. ■ °-95%
95% confidence limits = i 2 J C' Wmstand. + C*V*test
= ± 2 Jsi.54 + C1.902
• ± 18.16%
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It was evident that the reproducibility of the T.P.T.Z. method 
was adversely affected by the fortuitous choice of a serum pool 
of low iron content (approximately 30 jjg/lOO ml). The test 
was therefore repeated on a serum pool of high (approximately 
400 Mg/lCK) mi) iron content. The standard deviation obtained 
was identical with that obtained for the pool of low iron content 
(4.2), however when this figure was taken in conjunction with the 
higher mean, a C.V.t t of 4.3$ was calculated and 95$ confidence 
limits for the overall procedure were therefore, 8.9$ at this 
level.
As has been previously stated the effect of desferrioxamine 
would be expected to be two-fold. Firstly the competitive effect 
of an additional chelator in the system, and secondly the loss of 
iron due to entrainment of the iron-desferrioxamine complex in 
the protein precipitate. These two effects may be separated by 
a study of the effect of desferrioxamine on the measvirement of 
iron in non-protein containing solutions. A range of iron standards 
were prepared as before and the absorption of the iron-T.P.T.Z. 
complex measures. The same range was then prepared and that each 
standard contained 16 mg/lOO ml desferrioxamine. This concentration 
was chosen as being compatible with the concentration of the chelator 
which would be achieved in vivo under the normal therapeutic dose 
of 90 mg/kilogram. Since the T.P.T.Z.-iron reaction is known to 
be pH sensitive, the pH of the desferrioxamine containing standards 
was measured.(44) There was no significant alteration in pH due 
to the addition of this quantity of desferrioxamine. The results 
obtained in this experiment are shown in Table IV. For comparative
23
Table IV
EFFECT OF DESFERRIOXAMINE ON ABSORBANCE 
OF AQUEOUS IRON SOLUTIONS
Iron conc. 
yg/100 ml
Absorption 
No D.F. added
Absorption, D.F. 
16mg/100 ml added
A. T.P.T.Z.
0 0.081 0.060
100 0.190 0.067
300 0.468 0.166
500 0.742 0.278
B. Dipyridyl
0 0.032 0.040
200 0.136 0.066
400 0.200 0.092
2k
purposes the results obtained in a similar experiment using 
dipyridyl as the chromogen are also shown. A very marked depression 
of absorption was observed with both chromogens in the presence of 
desferrioxamine. Since the concentration of desferrioxamine in 
each tube was in excess of that required to chelate all the iron, 
it is evident that the conditions of these methods are such that 
neither the reduction of ferric iron nor the affinity for iron of 
the chromogen are sufficient to break completely the chelate.
To examine the effect of desferrioxamine on the quantitation 
of iron in serum by the T.P.T.Z. method, increasing quantities of 
desferrioxamine were weighed accurately into aliquots of a serum 
pool. Each aliquot was then quantitated for chromogen-available 
iron. The experimental results are presented in Figure 2. Again 
a marked inhibition of iron-T.P.T.Z. complex fonnation was noted. 
When the data from Figure 2 were compared with these shown in 
Table IV it is evident that the inhibition is less pronounced in 
protein containing solution than in aqueous solutions. At the 
300 |jg/l00 ml level in aqueous solution 160 |jg desferrioxamine/ml 
causes a reduction of 6%, while in serum the same quantity of 
chelator apparently reduces the iron level from 272 pg/100 ml to 
207 ng/lOO ml, a reduction of 2k<f>. The reason for this difference 
which is unexpected on the theorectical grounds stated earlier, 
must be that in serum the desferrioxamine chelate is formed only 
after the iron is released from transferrin and at that stage is in 
the presence of a reducing agent, once reduced, iron will not 
combine with desferrioxamine but is available to the chromogen.
In non-protein containing solutions, however, the chelate
25
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Figure 2. The effect of increasing concentration of desferrloxara 
on the results obtained for serum iron by T.P.T.Z. meti
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is formed immediately following the addition of desferroxamine.
Imhof has stated that the iron chelate of desferrioxamine 
can be broken by heat and acidification.(135) With this aim it 
was decided to attempt to modify the T.P.T.Z. method in order to 
remove the depressive effect of desferrioxamine. The modification 
consisted of the addition of 0.5 ml of IN hydrochloric acid to %
0.5 ml of the protein free supernatant fluid, and heating the 
mixture for 10 minutes at 5T°C. Before the effect of this 
modification on the inhibition of color formation could be tested, 
it was necessary to re-examine the overall procedure to determine 
the effect if any, on reproducibility. The results are shown 
in Table V. Overall reproducibility was improved as compared 
with the non-modified method. This improvement was primarily due 
to the greater absorbance of the serum sample since the standard 
deviation was considerably higher. The modified procedure was then 
tested in an experiment similar to that performed to determine 
the depression by desferrioxamine in the original T.P.T.Z. method. 
The serum pool and the quantities of desferrioxamine added were 
identical with those used in the earlier experiment, so that 
the results shown in Figure 3 are directly comparable with those 
in Figure 2. The results obtained by the modified method were 
in every case higher than those given by the original. This would 
indicate that not only does the acid-heat treatment cause a 
breakdown of iron-chelator complex, but also that even m  the 
absence of chelator the original method does not measure total 
iron. Figure 3 further shows that in contrast with Figure 2 
there is an erratic rather than a progressive depression of
27
Table V
REPRODUCIBILITY OF MODIFIED T.P.T.Z METHOD
A. Serum Blank Test T-B(x) x-R
1.
2.
3.
4.
5.
6.
063
055 
059 
057
056 
050
390
391 
408 
403 
400 
398
327
336
349
346
344
348
22.8
13.8
0.8
3.8
5.8
1.8
Ex = 3848
n = 11
x = 349.8
I(x-502 = 1495.6
I(x-x)2 _ 149#56 
n-1
7.
8.
046
050
392
412
346
362
3.8
12.2 /l(x-x)* _ 2.2.23 = S.D. 7 n-1
9. 046 408 362 12.2 X 100 = c.v.v10.
11.
047
047
408
414
361
367
11.2
17.2
A
C,V,test = 3*50%
B. 300 tig 
Standard
1 . 034 637 603 1.2 Ex = 6042
2. 034 637 603 1.2 n = 10
3. 044 648 604 0.2 x = 604.2
4. 036 636 600 4.2 Z(x-x)2 = 179.6
5. 038 636 598 6.2 Z(x.~L)2 = 19.96
6. 041 641 600 4.2 n-1
7.
8.
033
035
641
642
608
607
3.8
2.8
/l_(x-x)2 _ _ S>D<
V n-1
9. 038 651 613 8.8 S,D* x 100 = c.v.X
10. 032 638 606 1.8 C.V. * J = 0.74% ’stand.
95% confidence limits = ± 2 Jc.V •stand. + ^‘^ 'test
= i 2 Jl2. 25 + 0.55
= 7.16%
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Figure 3 * Results obtained for serum iron in the presence of 
increasing concentrations of desferrioxamine by- 
modified T.P.T.Z. method.
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iron-chrcmogen formation making it impossible to draw a meaningful 
inhibition curve. When, however, a line of best fit was drawn 
the inhibition produced by 160 |jg desferrioxamine/ml was 17$ 
as compared with 24$ by the same quantity of desferrioxamine in 
the original method.
Hie randomness seen in Figure 3 was also observed when a 
series of 9 serums were quantitated for total iron by the original 
T.P.T.Z. method and the modified procedure, in the presence and 
absence of desferrioxamine. The results of this series are shown 
in Table VI. No correlation between the figures obtained for 
any serum was observed. The reason for this lack of correlation 
is unknown. However it is readily apparent that the modification 
while improving the original procedure is unsuitable for the 
measurement of serum iron in the presence of desferrioxamine.
It is the conclusion based on the data obtained in these 
preliminary studies, that not only are none of the methods tested 
valid for the measurement of serum iron in the presence of 
desferrioxamine, but also the general lack of reproducibility, and, 
with the exception of the T.P.T.Z. methods, poor sensitivity 
make them inadequate for the reliable deteimination of serum 
iron under any conditions*
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ATOMIC ABSORPTION SPECTROSCOPY
Introduction
Historical* In 1802, Wollaston, the English astronomer, 
observed several dark bands in the spectrum of sunlight. A 
similar observation was made in l8l^ by Fraunhofer who was able to 
map some 500 of these lines which now bear his name. Neither of 
these investigators however understood the nature of the lines.
In i860 Kirchoff and Bunsen in their series of papers on spectro- 
chemical analysis demonstrated that these lines were due to 
absorption and that for example, those seen at the sodium D lines 
in the solar spectrum were due to the absorption of radiation by 
sodium atoms in the outer atmosphere of the sun.(l36)(l37)(l38) 
This work also indicated the potential of atomic spectra, either 
as emission or absorption, as an analytical tool. Since that 
time until recently emphasis has been on emission techniques, and 
with the exception of a few isolated examples, no practical 
application of atomic absorption has been made.
m  1953 Walsh recognized the potential of atonic absorption 
and devised the instrumentation for its utilization. (l^l) The 
first papers describing the application of atonic absorption 
techniques to chemical analysis appeared in 1955 • (l1*2)(1^ 3 Xl1*-1*1) 
Since that time interest has grown rapidly, indeed few subjects 
have been so extensively reviewed in such a short time.(1^5Xl^) 
(llH)(lU8)(lto)(150)(l5l)(l52)(l53)(l51<-)(l55)(156)(l57)
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It is however only within the last five years that this interest 
has spread from metallurgical applications to biology. In the 
main, methods for the analysis of biological material have been 
particularly directed toward those metals which are present 
in relatively high concentrations; these include sodium, potassium, 
calcium, and magnesium.(I58)(l59)(l60)(l6l)(l62)(l63)(l61+)(l65)(l66) 
(167) (168) (169) (170) (lTl) (1T2) The quantitation of trace metals 
has been less successful and has produced few publications. This 
is due primarily to the difficulty in achieving sufficient 
sensitivity at the level of 1 ppm (100 (jg/lOO ml) or less.
Recently however reports on the measurement of copper, zinc, and 
lead in biological material have appeared.(173)(17*0(175)(176)(177) 
In the case of serum iron however, no techniques, with the exception 
of one unsatisfactory method promulgated in a commercial house 
journal, have been published.(178) Zettner has stated that the 
proximity of serum iron levels to the limit of detectability 
(defined as that concentration of metal giving 1$ absorbance) 
for this element would require either the concentration of iron 
by extraction into an organic solvent or a hundred “fold increase 
in sensitivity.(154)
Principles of Atomic Absorption Spectroscopy
When metals are heated to their boiling points, they vaporize 
as free atoms. Some of these atoms may be further excited to a 
level such that on their return to the ground, or unexcited, state 
they emit energy in the foim of light. This phenomenon is the 
basis of emission flame photometry. The ratio of the number of 
atoms at any time in the excited state to the number in the ground
33
state is extremely small. It is a function of both the energy 
difference between the two states, which is specific for each 
element, and to the temperature of the flame in which the metal 
is vaporized. For example sodium which is one of the more easily 
excitable elements shows a ratio of excited to unexcited atoms 
of 1:10^ at 2,000°C. Increasing the temperature to 4,000°C changes 
this ratio to 1:10 . For this reason emission of flame photometry 
while an excellent technique for easily excitable alkaline metals, 
has proven less satisfactory for other elements. However, as was 
described in the previous section, atoms in the ground state can 
absorb light at one or several well defined wavelengths. These 
wavelengths are entirely characteristic and specific for each 
element and to date no two elements have been found to possess 
the same spectral line. Each element may have several spectral 
corresponding to the energy changes from one electronic configuration 
to another. This is especially true of the transition elements, 
including iron, which possess complicated electronic structures 
and may have a large number of spectral or resonance lines. It 
is most usual in atomic absorption spectroscopy to use that 
resonance line which corresponds to the transition from the ground
state to the lowest excited level.
The width of these resonance lines is theoretically very small
being of the order of W *  A. In practice although sme broadening 
does occur, the worKing width Is still onljr between 10' 2 and ICf1 A. 
In order to utilize such a narrow absorption line a light source 
of extreme sharpness is required, that is the source should be 
nearly as possible monochranatlc. Such a degree ofas
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monochromatism would "be unobtainable with a conventional source
and by using a prism or diffraction grating monochromator. If,
however, a hollow cathode lamp (see later) is used, the spectral
-2 ?width of the monochromatic light produced is of the order of 10 A. 
If the hollow cathode of the source lamp is constructed of the 
metal to be determined the major emission lines of such a lamp 
will coincide exactly with the resonance line of the metal in the 
flame. Furthermore, the width of each line will be compatible 
with excellent resolution. Under the conditions of the metal of 
the hollow cathode being also present in the flame, the flame will 
be opaque for the emissions of the source lamp but transparent at 
nil other wavelengths. The degree of opacity will be a function 
of the number of atoms of the metal under investigation present 
in the ground state in the flame. Indeed under ideal conditions 
absorption will be proportional to the concentration of absorbing 
atoms; that is it will obey Beer’s Law.(179) However, due 
mainly to the necessity of instrumental compromises, ideality is 
seldom achieved in practice. In summation an atomic absorption 
spectrophotometer operates on the following principle* light of 
extreme monochromatism is produced by a special source, it is 
passed through a flame in which is present a cloud of neutral 
activated atoms. Light is absorbed by these atoms in the flame 
which are in the unexcited or ground state. This reduction in 
light is detected by a photomultiplier tube, amplified and 
recorded on a read-out system.
Tn strumentation
The o«rall configuration of a typical single-beam atomic
35
absorption spectrophotometer is shown in Figure ^ (a). Each 
component will be described separately.
(a) The Hollow Cathode Lamp.(l80)
A hollow cathode lamp consists of an anode which is 
usually a tungsten rod and a hollow cylindrical cathode consisting 
of, or lined with the metal whose spectrum is desired. The 
electrodes are mounted in a sealed tube the front window of which 
is optically flat and if the emitting light is in the ultra­
violet, is made of quartz. The atmosphere within the tube is made 
up of a noble gas at a pressure of a few millimeters of mercury.
When a voltage is applied across the electrodes the filler gas 
becomes partially ionized. If however, the pressure of the filler 
gas is correctly adjusted this ionization is confined to the 
interior of the hollow cathode. The bombardment of the hollow 
cathode by the ions of the noble gas causes atoms of the metal of 
which the hollow cathode is made to be sputtered off. These metal 
atoms in turn collide with atoms of the filler gas causing the 
metal atoms to change their electron configuration with a 
subsequent emission of light of sharp spectral quality. The 
intensity of the light produced is directly proportional to the 
current across the electrodes and to the atomic weight of the filler 
gas. With increasing hollow cathode amperage there is however, 
an increase in the width of the spectral line, and the population 
of sputtered-off atoms within the lamp increases to the extent 
that some of these atoms absorb the emitted light. This widening 
of spectral lines and self-absorption generally results in a 
decrease in sensitivity. On the other hand, hollow cathode lamps

Figure b (a) Schematic diagram of atomic absorption spectro­
photometer. (b) Multiple pass system for use with 
total consumption burner.
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require a certain minimum amperage if stability is to be 
achieved. The choice of the working amperage is therefore a 
compromise between stability and sensitivity.
(b) Bumer-atamizer.
Following flame emission techniques the early burners 
used in atomic absorption spectrophotometry were of the slender 
turbulent flow type. It quickly became apparent that such a flame, 
while ideal for emission work, was unsuitable for atomic absorption. 
The use of an elongated flame peimitted the light beam to traverse 
a long light path within the flame and thereby increase sensitivity. 
These conditions were Impossible to achieve with turbulent flow 
burners. To circumvent this difficulty several workers adapted 
or designed new burners in which the fuel, air, and atomized sample 
were premixed in a discharge type atomizer, and the mixture burned 
in a fish-tail or elongated-slit burner.(l62)(l8l) This permitted 
the use of light paths of 10-12 centimeters. The advantages of 
this type of burner are, in addition to that stated above, the low 
level of flicker and turbulence produced give a more stable output, 
and since the sample is premixed, larger particles do not reach 
the flame to cause light-scattering but are drained off to waste. 
The major disadvantages of the pre-mix burner are its high sample 
consumption k-20 ml/minute, a relatively long "memory" due to the 
large volume of the atomizer, and the difficulty in cleaning the 
system should it become clogged. These disadvantages have 
recently caused a re-examination of turbulent flow burners in 
which the total sample passes through the flame. Modern 
total consumption burners consist of three concentric tubes through
38
which pass the fuel, oxidant, and sample. All of the tubes end 
at the same level where the shearing effect of the oxidant causes 
the aspiration of the sample. The use of such a total consumption 
burner permits the reduction of sample flow to less than 2 ml/minute. 
The problem of the short light path has been attacked in two ways.
The first being the use of several, usually three, burners. This 
negates to a large extent the advantages of reduced sample flow and 
further introduces the very considerable problem of balancing the 
burners for stable output. The second approach is to pass the 
light beam through the flame several times by means of lenses and 
mirrors. The arrangement of such a multiple pass system is shown 
in Figure k (b). This system has been found to work well although 
the increase in sensitivity is not as great as would be expected 
since the beams pass through different regions of the flame and 
there is always a small area in the flame, usually about 1 centimeter 
above the orifices, where maximum absorption is obtained.(182) While 
it might be expected that the efficiency of the total consumption 
burner would be greater than that of the pre-mix type, comparison 
shows both to have approximately the same efficiency. This finding 
is apparently due to the extremely rapid passage of material 
through the flame of total-consumption type burners, estimated a 
several meters per second, causing many atoms to fail to absorb.
(c) Monochromator
The requirements in a monochromator used in atomic 
absorption spectrophotometry are straight-forward. It must have 
the ability to pass the resonance line of the metal under 
investigation while screening out the nearest secondary line of
that element, and the primary and other lines of other elements* 
Among the elements whose resonance lines lie close together is 
iron with a separation of only 5 A between the major line at 
2483 A and a secondary line at 2488 A. A further requirement is 
that the monochromator should be able to achieve this resolution 
at as great a slit-width as possible, since the sensitivity of the 
measurement will be related to the amount of light entering the 
monochromator •
(d) Amplifier
In order to reduce the emission of the metal under 
investigation it has become standard practice to modulate the out­
put of the hollow cathode lamp and to amplify only the alternating 
current response of the photomultiplier tube. In some instruments 
the problem of emission is further reduced by maximally defocusing 
the light emitted by the flame at the entrance slit of the mono­
chromator, where the light from the hollow cathode lamp is 
maximally focused*
Atomic Absorption Spectrophotometry Methodology
The standard procedure for quantitating metals by atomic 
absorption spectrophotometry is to aspirate an unmeasured volume 
of liquid sample. The degree of absorption is read from a meter 
or strip-chart recorder. Presentation of results is usually either 
as per cent transmission (T) or more frequently as per cent 
absorption (100-T). This value may be then converted in 
absorptivity (2-log T). This however is frequently unnecessary 
if the working range is narrow and the concentration low. Even 
under ideal conditions it is usual for the graph produced by a
ko
series of concentrations determined as above, to curve towards the 
concentration axis. This is true even when absorptivity is plotted 
against concentration. The reason for this departure from linearity 
is not understood, but it has been suggested that it may be caused 
by atomic fluorescence* This is due to the fact that as atoms in 
the flame absorb the radiation of the hollow cathode source they 
are raised to a higher energy level. In their return to the 
ground state the absorbed energy is emitted at the resonance 
wavelength. (183) (184)
Interferences
Physical interferences are of small consequence in atomic 
absorption spectrophotometry. Spectral interference, a source of 
great difficulty in emission spectroscopy due to the excitation of 
elements other than the one under study, is not a problem as such 
in absorption work. A type of spectral interference may however 
occur due to the emission of complex spectra by the hollow 
cathode lamp. As indicated earlier this can be eliminated by the 
use of a monochromator of 0.2 A resolution. Another physical 
interference is the reduction of the atomic population of the flame 
by ionization. This is however only a problem with those metals 
with low ionization potentials such as potassium. (185) Further­
more since the degree of ionization is dependent on the flame 
temperature this interference can be easily eliminated.
Chemical interferences have on the other hand proved much 
more troublesome in absorption spectrophotometry. The formation 
of refractory salts reduces the number of atoms in the flame.
This effect is particularly strong in the case of phosphate, but
h i
has also been reported for other anions.(163)(l86) The interference 
due to anions may be frequently overcome by the addition to the 
solution of a cation with a greater affinity for the offending anion 
than that of metal under study, for example lanthanum or strontium 
will eliminate the inhibition of absorption of calcium caused 
by phosphate.(187)(188) A second method is to protect the metal 
by the formation of a chelate which subsequently breaks down in the 
flame.(160)(163)(189) These methods have not proved completely 
successful in all cases, and anionic interference remains the most 
serious methodological obstacle in the use of atomic absorption 
spectrophotcmetric techniques.
THE DEVELOPMENT OP A TECHNIQUE FOR THE MEASUREMENT OF IRON 
IN SERUM OR PLASMA BY ATOMIC ABSORPTION SPECTROPHOTOMETRY
Materials and Methods
The atomic absorption spectrophotometer used in these studies 
was a Jarrell-Ash model 82-362 single beam instrument, equipped 
with a Zeiss total consumption burner, except where otherwise 
indicated. This instrument incorporates an Ebert half-meter 
monochromator with a diffraction grating giving a resolution of
0.2 A. The readout system supplied is a 4-inch scale meter 
calibrated from 0-100 $ absorption. This instrument was subsequent­
ly adapted extensively as described in the text.
Iron standards were prepared as detailed in the section on
the colorimetric iron methods.
Plasma hemoglobin methods were deteimined by a colorimetric
method as follows :(190)
Reagents
1. Benzidine hydrochloride. 1 gram of benzidine hydrochloride 
was dissolved in 30 ml of deionized water with the aid
of heat. 50 ml of absolute ethanol was added, followed by 
20 ml of glacial acetic acid. This solution was prepared
immediately before use.
2. Hydrogen peroxide (0.6$). Prepared by diluting 1 ml of 
30$ v/v hydrogen peroxide to 50 ml with deionized water
immediately before use.
3. Acetic acid (20$ v/v).
U. Ammonium hydroxide (0.057 M). 0.1»- ml of 1^.3M ammonium
hydroxide was diluted to 100 ml with deionized water*
5. Stock standard hemoglobin solution. 0.1 ml of whole blood 
was washed into a 25 ml volumetric flask containing approx­
imately 2k ml 0.057M ammonium hydroxide, and made up to 
25 ml with the amonium hydroxide solution. The solution 
was read in a spectrophotometer at 5^2 m|i. The concentration 
of this solution was determined from the equation: (191)
mg Hemoglobin/100 ml _ Absorptivity x 28.2 x 1000
250
6. Working standards. The stock standard solution was diluted 
to provide a series of standards covering a range of 0 to 
10 mg hemoglobin/100 ml.
Procedure
1 . 0.1 ml of plasma was washed into a 15 ini stoppered
centrifuge tube containing 2 ml of benzidine solution.
At the same time the standard solutions are similarly
treated.
2. The tubes were then placed in a water bath at 20°G 
together with the bottle containing the hydrogen peroxide
solution*
3. After five minutes for temperature equilibration, 1 ml 
of hydrogen peroxide solution was added to each tube.
I4.. The tubes were stoppered, covered with a dark cloth, an 
allowed to incubate for sixty minutes.
5. At the end of this period 10 ml of 20# acetic acid was
added to each tube.
3^
6. After standing for ten minutes to allow color development, 
the contents of each tube were read in a spectrophotometer 
at i»-90 mu against a deionized water reference cuvette.
7 . Results were calculated by comparison with the standard 
curve, after subtraction of the blank.
Initial Studies on Sensitivity and Reproducibility
Initial studies on the reproducibility of atomic absorption 
spectrophotometry for the measurement of iron were performed on a 
range of aqueous standards. The instrumental variables were set 
according to the recommendations of the manufacturers for this 
element; these are shown in Table VII. The results obtained for 
these reproducibility studies are shown in Tables VIII ~ XII.
The standard deviations obtained were consistently below 0.4$ 
absorption vhlle the mean coefficient of variation over the 
range 5O-5OO pg/lOO ml was 4.76$. When two serum pools were 
quantitated in the same way standard deviations of the same order 
were obtained, as shown in Tables XIII and XIV. When the mean 
coefficient of variation of these serum pools was used m  
conjunction with the standard values a 95$ confidence limit of
+ 12.4$ was obtained.
A standard curve determined from aqueous solutions was run
to assess the sensitivity and linearity of the procedure. As
shown in Figure 5 good linearity over the lover range was
obtained with a marked bending towards the concentration axis
at the higher concentrations.
It was felt that these results were encouraging in the broad
 ^ -noint Of view of reproducibility,sense, although unacceptable from the poi
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Table VII
INSTRUMENTAL SETTINGS FOR INITIAL STUDIES ON REPRODUCIBILITY 
OF MEASUREMENT OF IRON IN AQUEOUS SOLUTION
Current to Hollow Cathode Lamp...................20 ma
Voltage to Photomultiplier Tube.............  500 volts
Air Pressure....................................5 psl
Hydrogen Pressure.............................. ..
Monochromator Entrance Slit ................. . ^
Monochromator Exit Slit................ 100 y
.......  2483 XWavelength..........................
Mp*terRead-Out System............. . . . ...........
.......  % AbsorptionQuantitation...................
.......  1 ZeissBurner. .............................
Total Consumption
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Table VIII
STUDY OF REPRODUCIBILITY OF MEASUREMENT OF IRON IN
AQUEOUS SOLUTIONS 1. 50yg Fe/100 ml Solution
Table IX
STUDY OF REPRODUCIBILITY OF MEASUREMENT OF IRON IN
AQUEOUS SOLUTIONS 2. lOOyg Fe/lOO ml Solution
Blank Test
X
Test-Blank x-mean
1. 2.50 8.50 6.00 0.01
2. 3.00 9.50 6.50 0.49
3. 3.50 1 9.75 6.25 0.24
4. 4.00 10.00 6.00 0.01
5. 3.50 9.50 6.00 0.01
Ex = 120.25 
x = 6.01, n = 20
6. 4.00 9.50 5.50 0.51 E(x-x)2 = 2.560
7. 3.50 9.50 6.00 0.01 E(x-x)2 _ o#128 n
8. 3.50 9.50 6.00 0.01
9. 4.00 9.75 5.75 0.26 ^Kx-x)2 _ 0>358 = s>Dt
10. 4.00 10.00 6.00 0.01 x ioo = c.v.
11. 4.00 10.00 6.00 0.01 X
12. 3.00 9.00 6.00 0.01 C.V. 0 = 5.96% 100yg stand.
13. 3.25 9.75 6.50 0.49
14. 3.00 9.00 6.00 0.01
15. 3.25 9.50 6.25 0.24
16. 4.00 9.50 5.50 0.51
17. 3.00 9.25 6.25 0.24
18. 3.25 9.50 6.25 0.24
19. 4.00 9.00 5.00 1.01
•oCN 3.00 9.50 6.50 0.49
H8
Table X
STUDY OF REPRODUCIBILITY OF MEASUREMENT OF IRON IN
AQUEOUS SOLUTIONS 3. 150yg Fe/lOO ml Solution
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Table XI
STUDY OF REPRODUCIBILITY OF MEASUREMENT OF IRON IN
AQUEOUS SOLUTIONS 4. 200yg Fe/lOO ml Solution
Blank Test
X
Test-Blank x-mean
1. 2.50 13.50 1 1 . 0 0 0.04
2. 3.25 14.25 1 1 . 0 0 0.04
3. 2.75 14.25 11.50 0.46
4. 2.75 14.00 11.25 0.21
Ex = 220.75
5. 3.25 14.50 11.25 0.21 x = 11.04, n = 20
6. 3.50 14.50 1 1 . 0 0 0.04 E(x-x)2 = 1 . 242
7. 2.75 14.25 11.50 0.46 E(x-x)2 = 0 . 062n
8. 4.00 14.75 10.75 0.29
9. 3.25 14.25 1 1 . 0 0 0.04 J E(x-x)2 = 0 . 249 = S.D.
10. 3.25 13.75 10.50 0.54 S.D. X 100 = C,,V.
11. 3.00 14.00 1 1 . 0 0 0.04 X
12. 3.50 14.50 1 1 . 0 0 0.04 C*V*200yg stand, = 2.26%•
13. 3.75 14.50 10.75 0.29
14. 3.00 14.25 11.25 0.21
15. 3.25 14.50 11.25 0.21
16. 3.50 14.50 1 1 . 0 0 0.04
17. 3.50 14.50 11.00 0.04
18. 3.50 14.25 10.75 0.29
19. 3.25 14.25 11.00 0.04
•oCM 3.50 14.25 10.75 0.29
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Table XII
STUDY OF REPRODUCIBILITY OF MEASUREMENT OF IRON IN
AQUEOUS SOLUTIONS 5. 500yg Fe/100 ml Solution
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STUDY OF REPRODUCIBILITY OF MEASUREMENT OF 
IRON IN SERUM 1. NORMAL SERUM POOL
Table XIII
Blank Test
X
rest-Blank x-mean
1. 3.00 11.00 8.00 0.13
2* 3.25 11.00 7.75 0.38
3* 3.50 11.50 8.00 0.13
3.50 11.25 7.75 0.38
Ex = 162.755. 3.25 11.50 8.25 0.12 x = 8.13, n = 20
6* 3.50 11.50 8.00 0.13 E(x-5?)2 = 4.75
7* 3.75 11.50 7.75 0.38 = 0.237n
8. 3.75 11.50 7.75 0.38
9* 3.50 , 11.50 8.00 0.13 Je(x-x)2 _ 0>H87 = s .d .
10. 3.50 11.75 8.25 0.12 X 100 = C.V.X
C.V. „ im = 5.99% serum
11. 3.50 11.75 8.25 0.12
12. 3.50 11.50 8.00 0.13
13. 3.75 11.75 8.00 0.13
14. 3.75 12.25 8.50 0.37
15. 3.75 12.25 8.50 0.37
16. 3.75 12.00 8.25 0.12
17. 3.50 12.00 8.50 0.37
18. 3.75 12.00 8.25 0.12
19. H.00 12.25 8.25 0.12
20. 3.75 12.50 8.75 0.62
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Table XIV
STUDY OF REPRODUCIBILITY OF MEASUREMENT OF
IRON IN SERUM 2. HIGH IRON CONTENT SERUM
Blank Test
X
rest-Blank x-mean
1 1* 3.25 32.00 28.75 1.32
1 2* 3.50 32.25 28.75 1.32
3* 3.25 32.50 29.25 0.82
4. 3.50 33.50 30.00 0.07
Zx = 601.50
5. 3.25 33.25 30.00 0.07 x = 30.07, n = 20
6* 3.75 34.50 30.75 0.68 I(x-3)2 = 6.99
j 7. 3.75 33.25 29.50 0.57 E_(x-x)2 _ 0>3^9 n
8. 4.00 34.00 30.00 0.07
9* 3.75 34.00 30.25 0.18
yzu-x)2 _ 0 # 5 9 1  = S > D .
10. 4.25 34.50 30.25 0.18 X 100 = C.V.
11. 4.25 34.75 30.50 0.43 C.V. = 1.96% serum
12. 3.75 34.75 31.00 0.93
13. 4.25 34.25 30.00 0.07
14. 4.25 34.25 30.00 0.07
15. 4.25 34.50 30.25 0.18
16. 3.75 34.25 30.50 0.43
17. 4.25 34.25 30.00 0.07
18. 3.75 34.00 30.25 0.18
19. 3.75 34.50 30.75 0.68
•oCM 4.00 34.50 30.50 0.43
Figure 5* Standard curve given by aqueous iron standards.
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Furthermore it was found to he extremely difficult to obtain 
an accurate reading from the meter due to fluctuations. Large 
quantities of sample were required and extreme caution was necessary 
before a confident figure could be recorded. In order to 
surmount this difficulty the output of the spectrophotometer was 
fed to a Sargent model SR variable range strip chart recorder.
This addition presented the opportunity to increase sensitivity 
by the incorporation into the circuit between the atomic absorption 
spectrophotometer and the recorder, of a scale-expanding device 
consisting of a variable bucking E.M.F. This zero suppression 
circuit permitted a theoretical expansion of 2,5, or 10 fold.
This circuit is shown diagramatically in Figure 6. The use of this 
device not only increases the recorder response to a given-signal 
but also amplifies to the same extent the electronic noise of the 
instrument, so that while a two-fold expansion was achieved, the 
higher amplifications were unusable with iron.
Since it was possible that the instrument settings used in 
the initial studies were not optimum, these were critically 
examined. Each variable was measured in turn while maintaining 
the others constant as shown in Figures 7, 8 and 9« Results were 
obtained by measuring the mean height of the recorder peaks in 
millimeters using two-fold scale expansion, so that 1# absorption 
was equal to 2 millimeters on the recorder chart paper. The 
conditions chosen on the basis of these results and used 
throughout the remainder of the study are shown in Table XV.
At this point in the investigation it became apparent that 
the fluctuations referred to earlier were as great a prob
:iv &L 31.'. , f : ri ' 'I.
.' - O: 'iOS&CC :^: r J' . : r '1 J-- <X--
Figure 6. Zero suppression circuit for adapting 10 mv recorder 
to atomic absorption spectroscopy.
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Figure 7* Determination of optimal conditions of instrument
variables, (l) Variation of voltage to photomultiplie
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Figure 9. Determination of optimal conditions of instrument 
variables. (3) and (4) Optimal gas pressures.
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Table XV
INSTRUMENTAL SETTINGS CHOSEN ON THE BASIS 
OF RESULTS SHOWN IN FIGURES 7*, 8, and 9
Current to Hollow Cathode Lamp. .. . . . . . . . . 2 0  ma
Voltage to Photomultiplier Tube.............  590 volts
Air Pressure..................................10 Ps^
Hydrogen Pressure.............  ................ 8 psi
Monochromator Entrance Slit ........................... ^
Monochromator Exit Slit........................ 100 y
Wavelength............................................. X
Read System................................Recorder
Quantitation..............................Integration
_ ......... 1 ZeissBurner.................................
Total Consumption
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when using the recorder as they had been using the meter. This 
was undoubtedly due to a combination of several factors: namely 
the partial clogging and clearing of the burner capillary, the 
differences in the viscosities of the samples, and even in the 
absence of these factors, variations in the flow rate through 
the flame# In an attempt to elucidate this problem the following 
experiment was set up.
A 50 nil serum pool was divided into two 25 ml aliquots. To 
one aliquot 25 pg of iron was added, the second was left untreated.
As a reference solution an aqueous iron standard containing 100 ng 
iron/100 ml was used. Approximately 20 determinations were made on 
the two serums, the standard, and a blank of deionized water. Each 
reading was obtained by aspirating exactly 1 ml of serum, standard, 
or blank. The flow rates were determined by timing with a stop 
watch. The recorder was set to run at maximum speed (5 inches 
per minute and two-fold scale expansion was used. The area under 
the recorder curve generated by each 1 ml sample was measured by 
cutting carefully around the pen trace and weighing. The results 
obtained are shown in Tables XVI - XIX. The mean value obtained 
for the iron content of the serum pool was 233/Mg/100 while 
the serum pool to which iron had been added assayed at 307 Mg/l°° *!• 
These figures indicated a mean recovery of only 7**. The reproduc­
ibility of the method based on areas was however good when the 
difficulty of cutting accurately around the recorder curve is 
considered. The 95# confidence limits of the method based on 
these figures were calculated to be 6.6#. The most significan 
aspect, however, of these data was the lack of reproducibility
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Table XVI
COMPARISON OF REPRODUCIBILITY OF FLOW AND AREA
UNDER RECORDER CURVE 1. ONE ML ALIQUOTS BLANK
X
Time 1 ml
Secs. x-x Weight g x-x
1. 17.30 0.7 0.0297 0.0012
2. 18.00 0 0.0312 0.0027
Ex = 324.8
3. 16.00 2.0 0.0276 0.0009 x = 18.0, n = 18
4. 17.00 1.0 0.0312 0.0027 E(x-x)2 = 25.38
5. 16.50 1.5 0.0299 0.0014 Z(x-*)2 = 1.41 n
6. 17.00 1.0 0.0273 0.0012 ^E(x-S)2 _ 1>18 _ S>D>
7. 18.60 0.6 0.0266 0.0019
8. 19.00 1.0 0.0235 0.0050 C,V*blank flow = 6,55%
9. 18.80 0.8 0.0318 0.0033
10. 17.60 0.4 0.0290 0.0005
11. 20.20 2.2 0.0246 0.0039 Ex = 0.5145
12. 18.40 0.4 0.0282 0.0003 X = 0.285, n = 18
13. 18.40 0.4 0.0293 0.0008 E(x-x)2 = 0.0000944
14. 18.00 0 0.0274 0.0011 E(x-x)2 _ 0#0000052 n
15. 17.60 0.4 0.0271 0.0014
16. 21.00 3.0 0.0282 0.0003 /e(x-x)2 _ n n n 9Qq = s.n.
17. 18.40 0.4 0.0324 0.0039 C-Hlank area =
18. 17.00 1.0 0.0285 0
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Table XVII
COMPARISON OF REPRODUCIBILITY OF FLOW RATES AND AREAS
UNDER RECORDER CURVE 2. ONE ML 100 g/lOOml STANDARD
Time 1 ml 
Secs. x-x Weight g x-x
7. 30.00 8.24 0.0610 0
8. 25.0 3.24 0.0596 0.0014
9. 22.0 0.24 0.0596 0.0014
10. 23.0 1.24 0.0620 0.0010
11. 22.0 0.24 0.0607 0.0003
12. 22.2 0.44 0.0603 0.0007
13. 19.8 1.96 0.0617 0.0001
14. 19.4 2.36 0.0609 0.0012
15. 19.4 2.36 0.0622 0.0012
16. 28.8 2.96 0.0589 0.0021
17. 20.0 1.76 0.0628 0.0018
18. 19.6 2.16 0.0610 0
19. 21.0 0.76 0.0656 0.0046
20. 20.5 1.26 0.0642 0.0032
Ex = 435.1 
x = 21.76, n = 20 
E(x-S)2 = 126.45
E(x-x)2 _ g#323
t-x)2 _
C.V.
= 2.52 = S.D.
= 11.58%stand, flow
Ex = 1.2211 
x = 0.0610, n = 20 
E(x-5D2 = 0.000057
E(x-g)2 _ 0.0000029n
< -x ) 2 _= 0.00167 = S.D.
p V =2.74-%L* stand. weight
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Table XVIII
COMPARISON OF REPRODUCIBILITY OF FLOW RATES AND AREAS
UNDER RECORDER CURVE 3. ONE ML ALIQUOTS POOLED SERUM
Time 1 ml 
Secs. x-5c Weight g x-x
1.
2.
3.
4.
5.
6.
7.
8. 
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20. 
21.
27.2
26.0
21.0
25.6
24.0
23.0 
21.8 
22.2 
22.2
19.0 
23.4
21.0 
19.6 
22.0 
18.8 
19.2
19.8 
20.0
19.0
23.0
20.8
5.4
4.2 
0.8 
3.8
2 .2  
1.2
0
0.4
0.4
2.8
1. 6
0.8
2.2
0.2
3.0 
2.6
2.0  
1.8 
2.8 
1.2  
1.0
0.1142 
0.1124 
0.1164 
0.1046 
0.1104 
0.1124 
0.1086 
0.1068 
0.1056 
0.0946 
0.1086 
0.0984 
0.1024 
0.1049 
0.1016 
0.1004 
0.0928 
0.0966 
0.0976 
0.0938 
0.0960
0.0099
0.0081
0.0121
0.0003
0.0061
0.0081
0.0043
0.0025
0.0031
0.0107
0.0043
0.0059
0.0019
0.0006
0.0027
0.0039
0.0117
0.0077
0.0067
0.0105
0.0083
Ex = 458.6 
x = 21.8, n = 21
E(x-x)2 = 126.16 
= 6.0n
I = 2.44 = S.D.n
C.V. .c, = 11.19%serum flow
Ex = 2.1903 
X = 0.1043, n = 21 
E(x-x)2= 0.001054
E(x-x)2 _= 0.000050n
/
E(x-x)2 _ o,00708 = S.D. n
C,V*serum weight = 6.78%
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Table XIX
COMPARISON OF REPRODUCIBILITY OF FLOW RATES AND AREAS 
UNDER RECORDER CURVE 3. ONE ML ALIQUOTS POOLED SERUM 
WITH ADDED IRON (lOOyg/lOO ml)
Time 1 ml 
Secs. x-x 1 Weight g x-x
1. 30.0
2. 19.6
3. 21.2
4. 22.2
5. 21.4
6. 24.8
7. 21.2
8. 21.2
9. 26.8
10. 31.0
11. 19.6
12. 20.6
13. 20.2
14. 20.4
15. 20.6
16. 21.4
17. 19.8
18. 20.4
19. 19.6
20. 19.6
21. 21.6
22. 20.6
8.01 
1.39] 
0.791 
0.211 
0.54 
2.81 
0.79 
0.79 
4.81 
9.01
2.39
1.39 
1.79
1.59
1.39 
0.59 
2.19
1.59
2.39
2.39 
0.39
1.39
0.1234 
0.1167 
0.1396 
0.1394 
0.1368 
0.1452 
0.1190 
0.1245 
0.1266 
0.1242 
0.1320 
0.1272 
0.1258 
0.1331 
0.1248 
0.1241 
0.1246 
0.1249 
0.1249 
0.1297 
0.1268 
0.1307
0.0049
0.0116
0.0113
0.0110
0.0085
0.0169
0.0093
0.0038
0.0017
0.0041
0.0037
0.0011
0.0025
0.0048
0.0035
0.0042
0.0037
0.0034
0.0034
0.0014
0.0015
0.0024
Ex = 483.8 
x = 21.99, n = 22 
E(x-x)2 = 213.54 
E(x-x)2
n = 9.706
/
£(x~5.)2. = 3.12 = S.D.
= 14.19%
n
C.V.serum flow
Ex = 2.8240 
x = 0.1283, n = 22 
E(x-x)2 = 0.0010066
E(x-x)2 _ o ^ 00001+5*7 n
/
E(x-x)2 _ 0.00675 = S.D.n 
C.V.serum area = 5.26%
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of flow rates, even those of aqueous, non-protein containing solutions. 
While it would he erroneous to interpret the coefficients of variation 
obtained as a reflection of the reproducibility of a method based on 
peak height as the means of quantitation, they are an indication of 
an important source of error. It was concluded that these re suit s 
indicated that peak heights were an inadequate means of quantitation 
for the determination of iron and other trace metals in a matrix 
such as serum when dilution is not practical. Firstly because of 
extremely erratic flow leading to difficulty in assessing true peak 
heights; and secondly and most important because of the invalidity 
of comparing peaks generated by solutions of differing viscosities.
It was decided therefore, to use the area generated by the 
recorder pen on the aspiration of a fixed volume (in most cases 1 ml) 
of solution. Since it was clearly impractical to use the method 
of cutting out the area and weighing as a routine procedure, the 
recorder was equipped with a Disc model 20k chart integrator.
This attachment mechanically measures the area generated by a 
tracing of any shape, the result being presented as an oscillating 
trace of a separate strip at the edge of the recorder chart. A 
typical presentation of peaks with their integrals is shown in 
Figure 10. Before this integrator was used for quantitation 
it was necessary to establish that the relation between the area 
described by the recorder pen and the number of integrator units 
was linear. This was achieved by causing the recorder, by means 
a£ the zero control, to describe a series of rectangular figures 
of increasing size. The areas of these rectangles was measured 
in square millimeters and compared with the number of integration
*dr). '' i ■ ■ . -  r .f  f •. . ♦.: f'5 . I  ?•,
.J39& &E 0 9 9  cJ f)3 .i * C  & &RUOSSB  ■SitlS-US'SOni
Figure 10. Recorder presentation given by serum to vhich 
increasing amounts of iron had been added.
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units as presented by the attachment* Figure 11 shovs the 
excellent linearity achieved*
The use of recorder curve integration as a means of 
quantitation depends on the hypothesis that irrespective of the 
time taken for a sample to pass through the flame, the area 
beneath the recorder curve will be a constant, provided the sample 
is not diluted below the limits of detectability. In order to 
test this hypothesis, a constant quantity of iron (5 pg) was placed 
in volumes of diluent ranging from 0.5 ml to 10 ml. The diluent 
in one experiment was deionized water and in the second experiment 
a solution containing 5 gram/lOO ml bovine serum albumin which had 
been made iron-free by repeated dialysis against tap water for four 
hours and against deionized water for twenty hours. The reason 
for the choice of this diluent is stated in the description of the 
next experiment. Each volume was then assayed for iron content 
together with a blank of identical volume and composition, with 
the exception of iron. The results obtained are shown'in 
Figure 12. As can be seen the hypothesis proved only partially 
correct. At a concentration above approximately 250 Mg iron/lOO ml 
(5 Mg/2 ml) the areas obtained deviated from the horizontal straight 
line that was expected. Hie explanation for this deviation must 
be, that under the conditions used, at concentrations of iron 
greater than 250 Mg/l00 ml, the flame becomes overpopulated with 
atoms, some of which pass through without absorbing light. While 
it is true that both standards and unknowns above 250 Mg/ 100 “1 
will behave in the same way, small variations from ideality will 
have a profound effect on the results obtained. It should be
68
; • ■ ■
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Figure 11. Correlation -between area and integrator units using 
Disc integrator.
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Figure 12. Areas generated by the same amount of iron in varying
volumes.
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emphasized that this overpopulation effect will he equally important 
as a source of error in a system using peak height as a means of 
quantitation.
It was realized that the use of an integrator could not he
%
expected to alter appreciably the extremely poor recovery obtained 
in the experiment where peak area was assessed by cutting out and 
weighing. This low recovery was felt to be due to a difference 
in composition between the standards and serum, that is it was a 
manifestation of chemical interference. To investigate this 
further, iron free protein solution was prepared as previously 
described. The dialyzed protein was concentrated by placing the 
dialysis sack in a beaker containing carbowax for approximately four 
hours. The protein concentration of this concentrated protein 
solution was determined by a biuret procedure.(192) The solution 
was then diluted to give a stock solution of 12 gram/100 ml. 0.5 ml 
of this solution was mixed with 0*5 ml of a range of iron standards 
of concentration 100 - 1000 pg/100 ml, to give a range of standards 
in 6 gram/100 ml protein solution, of 50 - 500 Mg iron/100 ml.
1 ml of these standards were quantitated together with aqueous 
standards of the same concentrations, and ten 1 ml aliquots of a 
serum pool, and ten 1 ml aliquots of the same pool to which had been 
added 100 Mg of iron/100 ml. The results obtained are plotted in 
Figures 13 and l1*-. Using peak heights (Figure 13) as the means of 
quantitation, the mean recovery against aqueous standards was 
agai n low (71*#), against the protein containing standards, however, 
the recovery was unacceptably high (130$). When results were 
computed using recorder curve integration, recovery against
■anr©2 entvoti tea aaosirpc n i snoi&uloa to a»vnua frea&critfs 
, noii s9±*x9roo€>«r to noe/iBarrao.*) Bxtb atfnaullb nljiva'Is
.noitsvxd-fisap t o  enssm as cjch+jiorj ilssor gnia.u xstutfsa jhotlI
Figure 13. Standard curves of solutions in aqueous and bovine se: 
albumin diluents and comparison of recoveries of iron 
from serum using peak heights as means of quantitatioi
S 1 H 0 I 3 H  X V 3 d  CH
WW2  = N O I l d a O S 9 V  % I WW Nl  S 1 H O I 3 H  M V 3 d
*is£*coo9tc snlau . '
!;■ "ic or:-x . ;
Figure lh. Comparison as in Figure 13 using recorder curve 
integration as means of quantitation#
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aqueous standards was Improved but still low (88#), but recovery 
against protein containing standards approached an acceptable level 
(95# with a coefficient of variation for 10 determinations of 
4.06#). This experiment reconfirmed the inadequacies of peak 
heights and further indicated that an effect of chemical inter­
ference was present in the system. The indication was, since 
levels of other ions were extremely low in the dialysed bovine 
serum albumin, that the interference was due to protein. This 
type of interference has been previously reported, but its nature 
is not understood.(154)(163)
To test the inhibition of absorption by protein, a 200 ng/l00 ml 
iron standard was prepared in a series of bovine albumin dilutions 
ranging from 0.265 gram/lOO ml to 2*65 gram/lOO ml. Since phosphate 
ion was known to be a potent inhibitor of absorption in the 
quantitation of other metals by atomic absorption spectrophotometry, 
a similar series of standards in protein were prepared with the 
addition to each tube of 5 mg phosphorous (as sodium phosphate)/l00 ml. 
The results of this experiment are shown in Figure 15. Very low 
concentrations of protein produced a marked inhibition of absorption. 
This inhibition decreases slightly with increasing protein concentration 
to about 1.5 gram/lOO ml, and then plateaus between this concentration 
and the highest tested. A similar iron standard diluted such that 
it contained 10 gram protein/100 ml gave a result which fell on 
this plateau. The addition of phosphate in a physiological 
concentration did not produce a cumulative inhibition. However, 
the marked inhibition of phosphate can be seen in the initial 
sample containing no protein. These results indicate that the
.(-IT. 00. '.-3M oos) n f' 1 r : V,:nx
Figure 15. Effect of increasing concentrations of albumin on 
standard iron (200 |jg/l00 ml).
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inclusion of protein in the standard solutions was essential, but 
that provided the protein concentration was greater than 1.5 gram/
100 ml the concentration is not critical. Since all serums will 
contain such a protein concentration no adjustment of the test 
solution is necessary. In order to eliminate the possibility that 
inhibition was due to some factor present in bovine serum albumin 
rather than to protein generally the same experiment was repeated 
using commercially prepared "ion free" human serum. This confirmed 
that the inhibition was indeed due to protein, since essentially 
the same results were obtained.
To elucidate the range of this effect, each of a series of 
standards from 0 to 250 |jg iron/lOO ml was prepared with no additions, 
with the addition of 5 mg phosphorous/lOO ml, with addition of 10 
gram protein/lOO ml, and with the addition of both phosphorous and 
protein. These standards were quantitated and the results plotted 
as shown in Figure 16. Inhibition throughout the whole range was 
observed with both protein and phosphorous, but once again no 
cumulative effect was caused when the two inhibitors were 
combined. The effect of increasing the concentration of phos­
phorous was found to be the same as that observed with increasing 
protein concentrations that is maximum inhibition at low concentrations, 
less than 0.5 rng/lOO ml with a plateau to 10 mg/100 ml.
Although not directly pertinent in the light of the above 
experiment, the effect of lanthanum and strontium on the inhibition 
by phosphate on the absorption of iron in non-protein containing 
solution was examined. 300 mg/100 ml of each of these elements 
were added to a range of aqueous iron standards and the samples
i ■ ( K: i c i 'j *. <•
nc/xi eirosups \cf nsvig tiot.icri.oa.-Ss 9A3 no niscfo*x.
Figure 16. Effects of phosphorous, protein, and phosphate and 
protein on the absorption given by aqueous iron
standards.
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aspirated. No removal of inhibition was observed, indeed in the 
case Of lanthanum there was a further depression in the readings 
obtained. When the chelator desferrioxamine was used in place of 
lanthanum and strontium, at a concentration of 10 mg/lOO ml, 
that is enough to chelate 850 Mg/lOO ml iron, a partial reversal 
of inhibition was obtained. These results indicated that the 
determination of iron by atomic absorption spectrophotometry in 
a non-protein solution containing phosphate such as urine, would 
require the addition of protein or other protecting compound as 
yet undescribed.
To eliminate the possibility of other ionic interferences, 
physiological amounts of sodium, potassium, magnesium, calcium, 
chloride, bicarbonate, phosphorous, and sulfate were added to a 
protein solution in sequence. A slight enhancement of absorption 
was observed following the addition of sodium chloride but this 
was removed by the addition of phosphorous. The integrator units 
given by the initial sample without additions were 44.5 and that 
obtained after the addition of all the above ions was 44. From 
this it was concluded that no other chemical interferences were 
present in the system and that the method was suitable for 
statistical evaluation of reproducibility and recovery of iron added 
to serum.
80 ml of a serum of low iron content was distributed in 80 
tubes and iron was added such that eight groups of 10 tubes were 
obtained containing a range of added iron from 0 to 233*3 ml.
Each sample was quantitated and the coefficients of variation and 
recovery of added iron calculated. The results are set out in
78
Tables XX and XXI. The results indicate a satisfactory degree of 
reproducibility and recovery, with perhaps the exception of the 
recovery at the lowest level. At this level however, an in­
crement of only 3*3 Mg of iron/lOO ml was being measured. When 
the integrator units for each level were plotted against concentration, 
Figure 17* good linearity was demonstrated. Recovery and reproduc­
ibility studies were also carried out on a serum of high iron 
content, although in routine practice this would be outside the 
advised limits of the method for reasons of flame overpopulation, as 
stated earlier, and such a serum would be diluted into the range 
below 250 |jg/lOO ml. The recovery range was from 400 to 750 pg 
iron/lOO ml. The mean recovery at these concentrations was found 
to be 97.14# + 1.62# coefficient of variation.
The overall confidence limits of the method were determined by 
the measurement of a series of standards in bovine serum albumin.
The range was 0 to 300 pg/lOO ml and ten tubes were quantitated at 
each level. Hie results are given in Table XXII. The mean 
coefficient of variation was calculated to be 3*05#. This value 
in conjunction with the coefficient of variation obtained for the 
serum samples gave 95# confidence limits for the whole procedure 
of + 6.88#.
To determine the normal range of the method and to assess the 
correlation with a colorimetric procedure, serum was drawn for 
eighteen healthy males. The iron levels of these sera were 
measured by atomic absorption spectrophotometry and by the color 
imetric procedure of Fischer and Price.(Wj-) The results obtained 
are shown in Table XXIII. The mean and range given by the
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Table XXI
RECOVERY OF ADDED IRON IN EIGHTY 
ALIQUOTS OF SERUM
Group
Mean 
Int. Units
Measured 
Iron Cone. 
yg/lOOml
Added
Iron
yg/lOOml
Recovered
Iron
yg/lOOml % Recovery
1 8.5 30.0 0 0 —
2 13.5 60.0 33.3 30 90.0
3 20.3 95.0 66.6 65 97.6
4 26.1 125.0 100.0 95 95.0
5 33.6 163.5 133.3 133 99.5
6 40.6 200.0 166.6 170 102.0
7 47.0 235.0 200.0 205 102.5
8 51.6 260.0 233.3 230 98.5
Mean % Recovery = 97.89% * 1.60%
:J . v -.V 39.^Ir>\‘ r ^ rx ben..' ;cJ" - c\ *."
.J.H 5 '^- 0? soIobj*
5 0
,ug ' R O N /  1 0 0 m l
*
Figure IT. Curve obtained from recovery values given in
Tables 20 and 21.
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Table XXIII
COMPARISON OF RESULTS OBTAINED BY ATOMIC ABSORPTION SPECTROPHOTOMETRY 
AND BY THE COLORIMETRIC METHOD OF FISCHER AND PRICE
Fischer-Price* 
g/100 ml
A • A. S.
pg/100 ml
**
1.
2.
3.
4.
5.
6.
7.
8. 
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
98
115
111
158
110
103
115
123
95
97
122
176
182
130
57
137
75
85
197
172
192
272
155
177
160
177
170
205
182
240
235
160
147
195
100
130
Ex = 2089 
X = 116, n = 18 
(x-x) = 17180
E(x-x)2 _
n
/
E(x-x)2
n = 31 = S.D.
Normal Range = x ± 2S.D. 
= 54-178 jig/100 ml
Ex = 3266 
R = 182, n = 18 
E(x-x) 2 = 28056 
E(x-x) 2 _= 1560n
/
E(x-g)2 = 40 
nNormal Range = x ± 2S.D. 
= 102-262 yg/100 ml
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colorimetric method were in good agreement with that published 
by Fischer and Price, whose mean and range were 120 and 75 - 
165 Mg.100 ml respectively.(k h ) However there appeared to be no 
correlation between the values obtained by the colorimetric pro­
cedure and atomic absorption spectrophotometry.
To explain this lack of correlation, it must firstly be 
emphasized that atomic absorption spectrophotometry will measure all 
iron in serum including that contained in hemoglobin. It has been 
shown that plasma hemoglobin is markedly lower than serum hemo­
globin. (193) It was decided therefore that plasma would be the 
preferable matrix in which to measure iron. To confirm this the 
above comparison was repeated on plasma obtained from twelve 
healthy adult males. The blood was collected by venipuncture 
using heparinized "vacutainer" tubes without any special precautions 
to avoid hemolysis other than those normally practiced. To determine 
the contribution to iron levels measured by atomic absorption 
spectrophotometry by plasma hemoglobin, hemoglobin levels were 
measured by the sensitive colorimetric procedure previously des­
cribed. The results obtained are shown in Table XXIV. As would be 
expected, the normal range for the colorimetric procedure was again 
in close agreement with the author*s figures. The normal range for 
iron of plasmas quantitated by atomic absorption spectrophotometry 
without correction for hemoglobin iron was very similar to that 
obtained for serum. The plasma hemoglobin content of these 
samples showed a range of 0-9*8 mg/lOO ml, which on the basis of 
an iron content of hemoglobin of 3.^ Mg per would contribute
0 to 29.2 |Jg of iron per 100 ml of plasma.(19*0 When the iron
85
COMPARISON OF RESULTS OBTAINED BY ATOMIC ADSORPTION SPECTROPHOTOMETRY 
AND THE COLORIMETRIC PROCEDURE OF FISCHER AND PRICE, WITH 
CORRECTION FOR IRON CONTENT OF PLASMA HEMOGLOBIN
Table XXIV
Fischer- 
Price 
Ug/100 ml
A.A.S. PI. Hb. Hb. Iron
yg/100 ml mg/1 0 0 ml yg/100 ml
Corrected 
A. A • S.
pg/100 ml
1.
2.
3.
4.
5.
6.
7.
8. 
9.
10.
11.
12.
133
132
121
143
110
115
75
180
74
80
124
112
Ex = 1399 
x = 117, n = 12 
E(x-x) 2 = 10251 
E(x-x) 2
n - = 854
Je(x-x) 2 = 29
275
255
255
270
175
210
150
190
130
160
180
150
5.0 
3.2
9.6
3.6
3.0
3.0
3.6
3.6 
4.9
6 . 6  
9.3 
3.8
17
11
33
12
10
10
12
12
14
19
32
13
Ex = 2400 
x = 200, n = 12 
E(x-x) 2 = 29300
Ex = 59.2
258
244
222
250
165
200
138
178
116
141
148
137
Ex = 2197
x = 4.93 ,n = 12 x = 183, n = 12
E(x-x)
/e(x-x)2 
V n
- = 2442
E(x-x) 2 = 71.07 
E(x-x)2 _
n 5.92
E(x-x) 2 = 27612 
E(x-x) 2 _
n = 2301
49 /E(x-x) 2 _ 2 .H3 n
J e(x-x )2
Range = 59-175 Range = 102-298 Range = 0-9.8
= 48 
Range = 87-279
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level of each plasma vas corrected for hemoglobin iron, the range 
was found to be 87-279 Mg/lOO ml. Plasma frcm thirteen adult 
females was assayed in the same way. A much greater scatter of 
results were obtained indicating, as has been stated by other 
workers, the difficulty of assessing the noimal range of iron 
values for a female population.(44)
The values given by atomic absorption spectrophotometry, while 
considerably higher than those of the Fischer and Price colorimetric 
procedure, are compatible with those published by other workers 
as shown in Table I. Since atomic absorption eliminates 
precipitation and extraction, it would be anticipated that the 
losses inevitably involved in these steps would account for the 
lower levels reported for most colorimetric procedures. This is 
substantiated by the higher levels given by the modification 
of the T.P.T.Z. method described, and by the work of Snith et al 
who used emission spectroscopy to arrive at a noimal range of 
plasma iron of 44-357 Mg/lOO ml.(l98)
THE REGULATION OP DESFERRIOXAMINE THERAPY IN 
ACUTE IRON INTOXICATION
One of the first experiments perforated with the atonic 
absorption spectrophotometer, was to determine in a way similar 
to that used with the colorimetric methods, the effect of increasing 
concentrations of desferrioxamine on the absorption given by 
aliquots of a serum pool, to which. 1000 pg of iron/lOO ml had been 
added. The results of this experiment are graphed in Figure 18.
No inhibition of absorption was observed up to concentrations of 
desferrioxamine in excess of that required to bind all of the 
non-transferrin bound iron. This experiment was performed using 
the initial conditions and therefore recovery of added iron was 
poor. However, as will be shown later, this lack of inhibition was 
also observed under optimal operating conditions and with recorder 
curve integration as the means of quantitation. It is evident that 
the temperature of the hydrogen-air flame (2300°C) is sufficient 
to disrupt completely the iron-de sf errioxamine chelate.
The problem of the regulation of desferrioxamine therapy 
can be divided into two parts. Firstly the determination of the 
distribution of serum iron into bound and unbound, as it would be 
in the presence of a serum desferrioxamine level below that 
required to chelate completely the non-transferrin bound iron, and 
secondly the measurement of desferrioxamine when it is in excess 
of that required to bind all non-transferrin bound iron.
The association constant of the iron-desferrioxamine chelate
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Figure 18. Effect of* increasing concentrations of desferroxamine 
on absorption of serum to which iron had been added.
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is of the same magnitude as the iron-transferrin complex, it 
was believed therefore that the first part of the problem could 
be solved by measuring the total iron binding capacity of the 
serum before and after desferrioxamine infusion. Since it has 
been shown that desferrioxamine will remove less than one per cent 
of the iron bound to transferrin, the figures obtained by 
subtracting the pre-treatment T.I.B.C. value from post-treatment 
figures will give the amount of desferrioxamine-bound iron. (126)
This figure taken in relation to the total serum iron level will 
permit the adjustment of the desferrioxamine serum level to the 
level of complete chelation. With this in view the method for 
T.I.B.C. of Ramsay was used with the atonic absorption spectro- 
photcmetric iron procedure, in place of the colorimetric 2,2*- 
dipyridyl reaction, as the means of quantitation.(195) The method 
consists of saturating the transferrin with added ferric ion.
The excess of this iron is then removed by adsorption on magnesium 
carbonate. For atomic absorption the procedure used was as 
follows: 0.5 ml of serum was pipetted into a test, tube containing
O.lf- ml of deionized water to which was added 0.1 ml of 10 mg/100 ml 
ferric chloride solution. The tubes were allowed to stand for 
fifteen minutes and 100 mg of magnesium carbonate powder were added 
to each tube. The tubes were shaken vigorously on a mechanical 
mixer and allowed to stand for thirty minutes. The tubes were then 
centrifuged for fifteen minutes at 3000 r.p.m. 0.5 ml of supernatant 
fluid was removed, diluted to 1 ml with deionized vater and quantitat­
ed for iron content by atomic absorption spectrophotometry. This 
procedure gave results vhich were comparable with, but slightly
90
higher than, those of other workers quoted earlier. The mean 
value obtained for twelve healthy males was 331 pg/lOO ml. The 
standard deviation for those sera of 57 |Jg/l00 ml gave a normal 
range of 217-44-5 pg/lOO ml. These higher values are explainable 
on the same grounds as the higher serum total iron levels obtained 
by atomic absorption spectrophotometry.
When this method was used in attempts to measure the iron- 
binding of desferrioxamine in vitro, the results obtained were not 
only erratic but obviously lower than would be expected from the 
theoretically mole for mole binding of iron by desferrioxamine.
This is illustrated in Figure 19 which shows the results of an 
experiment in which desferrioxamine was added in increasing amounts 
to an iron-free albumin solution which of itself had no iron-
binding capacity.
Whitten et al have recently shown that the binding of iron 
by desferrioxamine is pH dependant, and that above pH8 the binding 
of ferric ions falls off rapidly. (133) When the pH of the test 
solutions was measured it was found to be between 9 and 10, see 
Table XXV. This explained the low results obtained. To overcome 
this problem a number of ion exchange resins were investigated 
for the removal of excess iron, none of those examined however 
removed iron reproducibly or completely in these circumstances.
The problem was therefore approached differently and a number 
of buffers studied in an attempt to find one which would stabilize 
the pH at an acceptable figure (i.e. less than 8) for a period 
long enough for complete adsorption of the excess iron onto magnesium 
carbonate. Such a buffer was found, its composition being 3.53 gram
' - .
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Figure 19. Iron-binding capacity of bovine albumin in the presence 
of desferrioxamine.
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Table XXV
DETERMINATION OF THE EFFECT OF TIME IN CONTACT WITH 
MAGNESIUM CARBONATE ON T.I.B.C., AND pH CHANGE 
WITH AND WITHOUT PHOSPHATE BUFFER
Time-min.* Buffer-ml T.I.B.C. Final pH
30-40 0 576 8.70
30-40 0.9 576 8.25
0 0.9 640 7.40
0.5 0.9 640 7.60
1 0.9 640 7.60
2 0.9 576 7.80
4 0.9 530 8.00
Each tube contained 1 ml of serum, 0.9 ml of water or buf­
fer, and 0 .1 ml of 100 yg/ml iron standard.
* This time is the interval between the addition of magnesium 
carbonate and the beginning of a 2 minute centrifugation followed 
by the immediate removal of the supernatant.
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disodium hydrogen phosphate and 3.39 gram potassium dihydrogen 
phosphate per liter. This pH 6.86 buffer maintained the pH of the 
serum-magnesium carbonate mixture below 8 for at least four minutes. 
This time proved more than adequate for the complete adsorption 
of non-bound iron by magnesium carbonate as shown in Table XXV.
The buffer caused no change in the standard curve obtained when it 
was used in place of deionized water to dilute protein containing 
standards.
This procedure was used in an attempt to measure the dis­
tribution of iron in vitro. The detailed procedure was as follows: 
two hundred (jg of ferric ion as ferric chloride was added to a 20 ml 
serum pool in which the initial concentration of iron and T.I.B.C. 
had been measured. Increasing amounts of desferrioxamine were 
added to 2 ml aliquots of this serum. Total serum iron was 
determined by the chromogenic procedure of Fischer and Price and 
by atomic absorption spectrophotometry. (44) The reason for 
repeating the experiment with a colorimetric method was that the 
determinations described in the preliminary investigations had 
been performed on serums in which the transferrin was unsaturated.
It was of interest to establish that the same inhibitory effect was 
present in a serum in which a considerable excess of non­
transferrin but desferrioxamine-bound iron was present. T.I.B.C. *s 
were determined by atomic absorption spectrophotometry on the 
supernatant fluid obtained after 1 ml of serum to which had been 
added 0.1 ml of 100 Mg/lOO ml iron standard, 0.9 ml of the 
phosphate buffer, and the indicated amount of desferrioxamine; 
was heated with 100 mg of magnesium carbonate for 3-* minutes and
centrifuged for 2 minutes at 3000 r.p.m.
Comparison of the values for total serum iron in the presence 
of increasing amounts of desferrioxamine by the colorimetric method 
with those obtained by atonic absorption spectrophotometry showed, 
Figure 20, that the recovery of added iron was unsatisfactorily 
low (72$) when measured by the chromogenic method. In contrast 
the recovery of iron quantitated by atomic absorption was excellent 
(98$). The graph again shows a pronounced depression in the iron 
values given by the colorimetric method in the presence of des­
ferrioxamine.
Figure 21 shows the results obtained for total iron bound by 
transferrin and by desferrioxamine in each aliquot. The concentration 
of "free" ferric ions was calculated by subtracting the total bound 
iron from the total iron in the sample. These figures were plotted 
as shown in Figure 21. As can be seen from this graph the increase 
in iron binding capacity was not linear except where the ratio of 
the concentration of free iron to chelator was high, in which case 
the Iron was chelated on an equimolar basis. As the ratio of free 
iron to chelator decreased there was what appeared to he an 
exponential departure frcm linearity, Figure 22. That this was 
in fact exponential was confirmed when the results were plotted 
on semi-logarithmic paper and a straight line obtained, Figure 23.
These results would suggest that the regulation of desferri­
oxamine therapy in acute iron intoxication requires the frequent 
monitoring of the distribution of the iron in serum and the 
adjustment of the administration of the chelator accordingly.
The second part of the problem of the regulation of
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Figure 20. Effect of Increasing concentrations of desferrioxamii 
on iron levels obtained by T.P.T.Z. method and by 
atomic absorption spectrophotometry.
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Figure 21. In vitro distribution of iron in serum in the presence 
of desferrioxamine.
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presence of increasing concentrations of 
desferrioxamine .
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Figure 23. Results from Figure 22 plotted on semi-logarithmic 
paper.
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desferrioxamine therapy would occur in the situation where excess 
desferrioxamine was present in serum. On the "basis of the previous 
experiment such a situation would he unlikely to occur in practice, 
however it was felt that this should be investigated. To achieve 
this it was necessary to devise a model situatJbn in desferrioxamine 
was known to he present unbound to iron and in addition available 
for metabolic disposal. This required an in vivo experiment. The 
animals chosen were dogs. The animals were pre-medicated with 
2 mg/Kg morphine sulfate Intramuscularly and 30 minutes later 
anesthetized with sodium nembutal 20 mg/Kg intravenously. A 
catheter was placed in the jugular vein and the standard therapeutic 
dose of desferrioxamine 15 mg/Kg in 10 ml of 0.8$ saline was given 
by this route over a period of 2 minutes. Samples were withdrawn 
by the catheter into heparinized tubes, the plasma removed and 
quantitated for desferrioxamine as previously described. The 
results of this experiment were comparable in the three animals 
thus treated, one of the series is plotted in Figure 2 k. It 
can be seen that desferrioxamine is cleared extremely rapidly 
from the blood and that by twenty minutes levels had returned 
to pre-treatment level. This would indicate that in the unlikely 
event of any excess desferrioxamine being present in the blood it 
vould be unmeasurable within a very short time. It will be 
observed that the level of total binding capacity of the dog 
serum fell below the pre-treatment level. This was also observed 
in a second dog but in this case sampling was continued to 120 
minutes at which time the iron-binding capacity had returned to the 
pre-treatment level. The explanation for this observation is
100
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Figure 2k. Disappearance of desferrioxamine from blood of dog.
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difficult to find, it is unlikely but nevertheless possible, that 
the control of transferrin levels is as precise and rapid acting 
that the levels are reduced in the presence of a similar ccmplexing 
agent. These results are in broad agreement with the in vivo 
degradlation ratio of desferrioxamine recently published by Peters. 
(196) Using tritiated desferrioxamine and large doses (300 mg/
Kg i.v.) of carrier desferrioxamine, he found a biological half- 
life for this chelator of approximately one hour in nephrectomized 
dogs. On the basis of this work and the observations made above, 
it would appear that desferrioxamine is removed from the body both 
by metabolism and renal excretion, with these components being of 
approximately equal magnitude.
These observations are of interest in the technical sense, but 
have little or no application in the clinical use of this chelator.
In the treatment of acute iron intoxication the important considerat­
ion is the- rate of removal of iron-chelate either by metabolic or 
renal processes. Of equal importance, however, is the differentiation 
of these components, since if the complex is metabolized the sub­
sequent release of iron would nullify treatment with desferrioxamine. 
These factors were examined by infusing the desferrioxamine-iron 
complex into a dog. 166 mg of ferrioxamine (containing 13 mg iron) 
were injected intravenously into a 10 Kg dog prepared and 
anesthetized as previously described. Blood samples were withdraw 
at timed intervals and total iron levels measured on the plasma.
The results plotted as a linear function of concentration against 
time are shown in Figure 25. The iron level immediately following 
infusion (2000 Mg-100 ml) agrees closely with that calculated on
xcJ-iifoo 3xoi*r.:: To of.xini at>r .
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Figure 25. Disappearance of iron-desferrioxamine complex from 
blood of dog.
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Figure 2 6. Semi -logarithmic plots of results shown in Figure 25 •

1^ 50 Mg iron/lOO ml at 10 minutes after the infusion. The 
ferrioxamine space calculated on this value was 900 ml for this
dog.
The results of this experiment again show broad agreement with 
those recently described by Peters who used tritiated ferrioxamine 
in both nephrectomized and intact dogs.(196)
CONCLUSION
The indication of the unsatisfactory nature of the methods 
for the determination of serum iron in current assays, given by 
a survey of the recent literature, has heen confirmed Toy a critical 
examination of three representative colorimetric procedures. The 
deficiencies of these methods were especially apparent when
desferrioxamine was present in the serum.
Atomic absorption spectrophotometry provided a technique 
which eliminated these deficiencies, which it is of interest to 
note have been very recently confirmed by Gevirts and Whsseman.(199) 
In order to utilise the technique of atomic absorption spectro­
photometer not only was it necessary to overcome the inherent 
chemical problems of measuring iron in biological material, but 
extensive modification of the available instrument was also 
required. The effects of differing viscosities of samples and
i •iminated by recorder curve integration based on 
standards were eliminated oy re
4. -i * This original concept conferred additional 
constant volume. This origi
advantages in that the instr^ental system as a whole was less
susceptible to the effects of partial blockage, and low signa
. . s than vas found to be the case in a system 
electronic noise ratios,
relying on more conventional means of quantitation.
The reproducibility and recovery achieved using the dev pe 
method were believed to represent a significant advance in t .  
measurement of ser. iron. The only possible disadvantage
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technique appeared to lie in the unavoidable measurement of iron 
present in serum or plasma in a form other than that usually 
included in the term "serum iron". The only significant artifact 
being hemoglobin. It was found however that the contribution of 
hemoglobin to the total iron measured in plasma was small.
Furthermore when the necessity of measuring plasma hemoglobin to 
assess its contribution to the total iron as measured by atomic 
absorption spectrophotometry, was obvious, as in the case of 
hemolysed samples or for extreme accuracy, the time involved for 
both the hemoglobin and atomic absorption measurements, was compatible 
with that required for the more widely used colorimetric procedures.
Determinations of the distribution of iron in the presence of 
desferrioxamine both in vitro and in vivo indicate the requirement 
for frequent monitoring of the iron ingestion patient on this 
therapy, with respect to his status of free iron relative to 
desferrioxamine bound iron. The experiments Indicate that 
desferrioxamine fulfill, in vivo requirements for the efficient 
removal of iron in excess of that bound to transferrin, and should 
therefore provide the most satisfactory means of treating the 
patient with acute iron intoxication available to date.
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